1	anti-inflammatory	JJ	O	anti-inflammatory	amod	2	SENT_1	[p1l10t362r590b432],
2	drugs	NNS	O	drug	nsubj	20	SENT_1	[p1l623t362r827b432],
3	,	,	O	,	_	0	SENT_1	[p1l623t362r827b432],
4	and	CC	O	and	_	0	SENT_1	[p1l865t362r984b417],
5	reduction	NN	O	reduction	conj_and	2	SENT_1	[p1l1023t362r1330b417],
6	or	CC	O	or	_	0	SENT_1	[p1l1367t376r1432b417],
7	interruption	NN	O	interruption	conj_and	2	SENT_1	[p1l1467t362r1839b431],
8	of	IN	O	of	_	0	SENT_1	[p1l1876t362r1939b417],
9	treatment	NN	O	treatment	nn	10	SENT_1	[p1l1969t365r2147b417, p1l12t449r225b519],
10	.2	NN	NUMBER	.2	prep_of	5	SENT_1	[p1l1969t365r2147b417, p1l12t449r225b519],
11	In	IN	O	in	_	0	SENT_1	[p1l271t464r322b518],
12	the	DT	O	the	det	14	SENT_1	[p1l364t464r467b519],
13	present	JJ	DATE	present	amod	14	SENT_1	[p1l511t467r757b533],
14	case	NN	O	case	prep_in	20	SENT_1	[p1l799t478r970b529],
15	,	,	O	,	_	0	SENT_1	[p1l799t478r970b529],
16	the	DT	O	the	det	18	SENT_1	[p1l1014t464r1117b519],
17	HFSR	NN	O	hfsr	nn	18	SENT_1	[p1l1161t463r1350b519],
18	severity	NN	O	severity	nsubj	20	SENT_1	[p1l1391t464r1647b533],
19	was	VBD	O	be	cop	20	SENT_1	[p1l1685t478r1817b519],
20	grade	NN	O	grade	_	0	SENT_1	[p1l1859t464r2048b533],
21	2	CD	NUMBER	2	num	20	SENT_1	[p1l2089t464r2144b518],
22	.	.	O	.	_	0	SENT_1	[p1l2089t464r2144b518],

1	The	DT	O	the	det	2	SENT_2	[p1l7t565r130b621],
2	patient	NN	O	patient	nsubj	3	SENT_2	[p1l188t566r412b635],
3	applied	VBD	O	apply	_	0	SENT_2	[p1l468t565r708b635],
4	topical	JJ	O	topical	amod	5	SENT_2	[p1l765t566r984b635],
5	urea	NN	O	urea	dobj	3	SENT_2	[p1l1045t579r1187b621],
6	and	CC	O	and	_	0	SENT_2	[p1l1242t566r1361b621],
7	emollient	JJ	O	emollient	conj_and	3	SENT_2	[p1l1420t565r1717b621],
8	for	IN	O	for	_	0	SENT_2	[p1l1771t565r1860b621],
9	several	JJ	DURATION	several	amod	10	SENT_2	[p1l1914t566r2145b621],
10	months	NNS	DURATION	month	prep_for	7	SENT_2	[p1l12t667r272b733],
11	,	,	O	,	_	0	SENT_2	[p1l12t667r272b733],
12	but	CC	O	but	_	0	SENT_2	[p1l312t667r415b723],
13	the	DT	O	the	det	15	SENT_2	[p1l446t667r549b723],
14	tender	NN	O	tender	nn	15	SENT_2	[p1l581t667r796b723],
15	sensation	NN	O	sensation	nsubj	18	SENT_2	[p1l827t667r1141b723],
16	did	VBD	O	do	aux	18	SENT_2	[p1l1177t667r1275b723],
17	not	RB	O	not	neg	18	SENT_2	[p1l1314t670r1415b723],
18	improve	VB	O	improve	conj_but	3	SENT_2	[p1l1451t667r1731b736],
19	.	.	O	.	_	0	SENT_2	[p1l1451t667r1731b736],

1	The	DT	O	the	det	2	SENT_3	[p1l1766t667r1889b723],
2	patient	NN	O	patient	nsubj	3	SENT_3	[p1l1924t667r2148b736],
3	underwent	VBD	O	undergo	_	0	SENT_3	[p1l12t769r360b825],
4	narrowband	NN	O	narrowband	nn	6	SENT_3	[p1l391t770r783b825],
5	UV-B	NN	O	uv-b	nn	6	SENT_3	[p1l819t770r991b825],
6	phototherapy	NN	O	phototherapy	dobj	3	SENT_3	[p1l1024t769r1465b839],
7	for	IN	O	for	_	0	SENT_3	[p1l1492t769r1582b825],
8	the	DT	O	the	det	9	SENT_3	[p1l1608t770r1711b825],
9	treatment	NN	O	treatment	prep_for	6	SENT_3	[p1l1738t772r2058b825],
10	of	IN	O	of	_	0	SENT_3	[p1l2088t769r2151b825],
11	psoriasis	NN	O	psoriasis	prep_of	9	SENT_3	[p1l12t872r320b941],
12	.	.	O	.	_	0	SENT_3	[p1l12t872r320b941],

1	Surprisingly	RB	O	surprisingly	advmod	5	SENT_4	[p1l353t870r756b941],
2	,	,	O	,	_	0	SENT_4	[p1l353t870r756b941],
3	the	DT	O	the	det	4	SENT_4	[p1l787t872r890b927],
4	HFSR	NN	O	hfsr	nsubj	5	SENT_4	[p1l923t870r1111b927],
5	improved	VBD	O	improve	_	0	SENT_4	[p1l1142t872r1447b941],
6	as	RB	O	as	advmod	7	SENT_4	[p1l1478t886r1552b927],
7	well	RB	O	well	advmod	5	SENT_4	[p1l1580t872r1724b927],
8	.	.	O	.	_	0	SENT_4	[p1l1580t872r1724b927],

1	Several	JJ	O	several	amod	3	SENT_5	[p1l104t973r345b1029],
2	cutaneous	JJ	O	cutaneous	amod	3	SENT_5	[p1l411t977r755b1029],
3	side-effects	NNS	O	side-effect	nsubjpass	6	SENT_5	[p1l819t973r1207b1029],
4	have	VBP	O	have	aux	6	SENT_5	[p1l1274t974r1428b1029],
5	been	VBN	O	be	auxpass	6	SENT_5	[p1l1493t974r1651b1029],
6	reported	VBN	O	report	ccomp	26	SENT_5	[p1l1719t974r1996b1043],
7	for	IN	O	for	_	0	SENT_5	[p1l2061t973r2150b1029],
8	sorafenib	NN	O	sorafenib	prep_for	6	SENT_5	[p1l9t1075r332b1141],
9	,	,	O	,	_	0	SENT_5	[p1l9t1075r332b1141],
10	including	VBG	O	include	_	0	SENT_5	[p1l413t1076r705b1145],
11	yellowish	JJ	O	yellowish	amod	13	SENT_5	[p1l780t1075r1081b1145],
12	skin	NN	O	skin	nn	13	SENT_5	[p1l1157t1076r1285b1131],
13	discoloration	NN	O	discoloration	prep_including	8	SENT_5	[p1l1362t1075r1804b1141],
14	,	,	O	,	_	0	SENT_5	[p1l1362t1075r1804b1141],
15	eruptive	JJ	O	eruptive	amod	17	SENT_5	[p1l1884t1076r2149b1145],
16	benign	JJ	O	benign	amod	17	SENT_5	[p1l12t1177r230b1246],
17	nevi	NN	O	nevus	prep_including	8	SENT_5	[p1l267t1177r394b1232],
18	and	CC	O	and	_	0	SENT_5	[p1l429t1177r549b1232],
19	psoriasiform	NN	O	psoriasiform	nn	22	SENT_5	[p1l587t1176r991b1246],
20	drug	NN	O	drug	nn	22	SENT_5	[p1l1026t1177r1173b1246],
21	eruption	NN	O	eruption	nn	22	SENT_5	[p1l1209t1162r1531b1246],
22	.3	NN	NUMBER	.3	prep_including	8	SENT_5	[p1l1209t1162r1531b1246],
23	Here	RB	O	here	advmod	6	SENT_5	[p1l1567t1177r1737b1242],
24	,	,	O	,	_	0	SENT_5	[p1l1567t1177r1737b1242],
25	we	PRP	O	we	nsubj	26	SENT_5	[p1l1772t1191r1867b1232],
26	present	VBP	DATE	present	_	0	SENT_5	[p1l1903t1180r2149b1246],
27	the	DT	O	the	det	28	SENT_5	[p1l8t1279r111b1334],
28	case	NN	O	case	nsubj	33	SENT_5	[p1l147t1293r302b1334],
29	of	IN	O	of	_	0	SENT_5	[p1l338t1278r401b1334],
30	hepatoma	NN	O	hepatoma	prep_of	28	SENT_5	[p1l437t1279r769b1348],
31	with	IN	O	with	_	0	SENT_5	[p1l803t1279r936b1333],
32	psoriasis	NN	O	psoriasis	prep_with	30	SENT_5	[p1l977t1279r1267b1348],
33	related	JJ	O	related	xcomp	26	SENT_5	[p1l1306t1279r1527b1334],
34	to	TO	O	to	_	0	SENT_5	[p1l1564t1282r1627b1334],
35	sorafenib	NN	O	sorafenib	prep_to	33	SENT_5	[p1l1664t1278r1987b1334],
36	.	.	O	.	_	0	SENT_5	[p1l1664t1278r1987b1334],

1	The	DT	O	the	det	2	SENT_6	[p1l2025t1279r2148b1334],
2	pathogenesis	NN	O	pathogenesis	nsubj	4	SENT_6	[p1l12t1380r453b1450],
3	remains	VBZ	O	remain	cop	4	SENT_6	[p1l510t1380r769b1436],
4	uncertain	JJ	O	uncertain	_	0	SENT_6	[p1l825t1380r1146b1446],
5	,	,	O	,	_	0	SENT_6	[p1l825t1380r1146b1446],
6	but	CC	O	but	_	0	SENT_6	[p1l1206t1380r1309b1436],
7	a	DT	O	a	det	9	SENT_6	[p1l1363t1394r1401b1436],
8	reduced	VBN	O	reduce	amod	9	SENT_6	[p1l1457t1381r1724b1436],
9	number	NN	O	number	nsubj	15	SENT_6	[p1l1783t1381r2035b1436],
10	of	IN	O	of	_	0	SENT_6	[p1l2088t1380r2151b1436],
11	immunosuppressive	JJ	O	immunosuppressive	amod	14	SENT_6	[p1l12t1482r676b1551],
12	regulatory	JJ	O	regulatory	amod	14	SENT_6	[p1l716t1482r1046b1551],
13	T	NN	O	t	nn	14	SENT_6	[p1l1079t1482r1123b1536],
14	cells	NNS	O	cell	prep_of	9	SENT_6	[p1l1159t1482r1306b1537],
15	(	VBP	O	(	conj_but	4	SENT_6	[p1l1345t1481r1404b1551],
16	T	NN	O	t	nn	18	SENT_6	[p1l1345t1481r1404b1551],
17	reg	NN	O	reg	nn	18	SENT_6	[p1l1408t1481r1528b1551],
18	)	NN	O	)	nsubjpass	20	SENT_6	[p1l1408t1481r1528b1551],
19	are	VBP	O	be	auxpass	20	SENT_6	[p1l1567t1496r1669b1537],
20	hypothesized	VBN	O	hypothesize	ccomp	15	SENT_6	[p1l1709t1482r2145b1551],
21	to	TO	O	to	aux	23	SENT_6	[p1l8t1587r71b1638],
22	have	VB	O	have	aux	23	SENT_6	[p1l119t1583r273b1638],
23	played	VBN	O	play	xcomp	20	SENT_6	[p1l320t1583r534b1652],
24	an	DT	O	a	det	26	SENT_6	[p1l582t1597r658b1638],
25	important	JJ	O	important	amod	26	SENT_6	[p1l708t1583r1022b1652],
26	role	NN	O	role	dobj	23	SENT_6	[p1l1069t1583r1205b1638],
27	.	.	O	.	_	0	SENT_6	[p1l1069t1583r1205b1638],

1	Dysfunctional	JJ	O	dysfunctional	amod	2	SENT_7	[p1l1257t1583r1699b1652],
2	CD4	NN	O	cd4	nsubjpass	20	SENT_7	[p1l1748t1579r2147b1639],
3	+	CC	O	+	_	0	SENT_7	[p1l1748t1579r2147b1639],
4	CD25	NN	O	cd25	nsubjpass	20	SENT_7	[p1l1748t1579r2147b1639],
5	+	CC	O	+	_	0	SENT_7	[p1l1748t1579r2147b1639],
6	Treg	NNP	ORGANIZATION	Treg	conj_+	4	SENT_7	[p1l7t1686r173b1755],
7	,	,	O	,	_	0	SENT_7	[p1l7t1686r173b1755],
8	which	WDT	O	which	nsubj	9	SENT_7	[p1l206t1685r398b1741],
9	cause	VBP	O	cause	rcmod	2	SENT_7	[p1l430t1699r626b1741],
10	an	DT	O	a	det	11	SENT_7	[p1l655t1699r731b1741],
11	imbalance	NN	O	imbalance	dobj	9	SENT_7	[p1l766t1686r1102b1741],
12	between	IN	O	between	_	0	SENT_7	[p1l1136t1685r1414b1741],
13	regulatory	JJ	O	regulatory	amod	17	SENT_7	[p1l1448t1685r1777b1755],
14	and	CC	O	and	_	0	SENT_7	[p1l1807t1686r1926b1741],
15	effector	NN	O	effector	conj_and	13	SENT_7	[p1l1958t1685r2147b1741, p1l8t1789r99b1841],
16	T-cell	NN	MISC	t-cell	nn	17	SENT_7	[p1l126t1786r307b1841],
17	functions	NNS	O	function	prep_between	11	SENT_7	[p1l340t1786r661b1851],
18	,	,	O	,	_	0	SENT_7	[p1l340t1786r661b1851],
19	are	VBP	O	be	auxpass	20	SENT_7	[p1l697t1800r799b1841],
20	found	VBN	O	find	_	0	SENT_7	[p1l829t1786r1016b1841],
21	in	IN	O	in	_	0	SENT_7	[p1l1054t1786r1102b1840],
22	patients	NNS	O	patient	prep_in	20	SENT_7	[p1l1139t1786r1400b1855],
23	with	IN	O	with	_	0	SENT_7	[p1l1431t1786r1564b1840],
24	psoriasis	NN	O	psoriasis	prep_with	20	SENT_7	[p1l1600t1771r1943b1855],
25	.4	CD	NUMBER	.4	num	28	SENT_7	[p1l1600t1771r1943b1855],
26	Tyrosine	NN	O	tyrosine	nn	28	SENT_7	[p1l1973t1786r2147b1855, p1l9t1888r141b1943],
27	kinase	NN	O	kinase	nn	28	SENT_7	[p1l178t1888r387b1943],
28	inhibitors	NNS	O	inhibitor	nsubj	35	SENT_7	[p1l423t1888r737b1953],
29	,	,	O	,	_	0	SENT_7	[p1l423t1888r737b1953],
30	such	JJ	O	such	_	0	SENT_7	[p1l776t1888r930b1943],
31	as	IN	O	as	_	0	SENT_7	[p1l967t1902r1041b1943],
32	sorafenib	NN	O	sorafenib	prep_such_as	28	SENT_7	[p1l1075t1887r1397b1953],
33	,	,	O	,	_	0	SENT_7	[p1l1075t1887r1397b1953],
34	may	MD	O	may	aux	35	SENT_7	[p1l1439t1902r1575b1957],
35	block	VB	O	block	rcmod	24	SENT_7	[p1l1611t1888r1789b1943],
36	the	DT	O	the	det	39	SENT_7	[p1l1820t1888r1923b1943],
37	signal	NN	O	signal	nn	39	SENT_7	[p1l1957t1888r2146b1958],
38	transduction	NN	O	transduction	nn	39	SENT_7	[p1l8t1989r420b2044],
39	pathways	NNS	O	pathway	dobj	35	SENT_7	[p1l458t1989r773b2059],
40	in	IN	O	in	_	0	SENT_7	[p1l809t1989r857b2044],
41	both	DT	O	both	det	46	SENT_7	[p1l895t1989r1038b2044],
42	regulatory	JJ	O	regulatory	amod	46	SENT_7	[p1l1076t1989r1405b2059],
43	and	CC	O	and	_	0	SENT_7	[p1l1437t1989r1556b2044],
44	effector	NN	O	effector	amod	46	SENT_7	[p1l1592t1989r1846b2044],
45	T	NN	O	t	nn	46	SENT_7	[p1l1875t1989r1918b2044],
46	cells	NNS	O	cell	prep_in	35	SENT_7	[p1l1949t1975r2148b2044],
47	.5	CD	NUMBER	.5	tmod	35	SENT_7	[p1l1949t1975r2148b2044],
48	We	PRP	O	we	nsubj	49	SENT_7	[p1l8t2091r115b2146],
49	suspect	VBP	O	suspect	rcmod	47	SENT_7	[p1l145t2094r406b2160],
50	that	IN	O	that	complm	56	SENT_7	[p1l434t2091r560b2146],
51	impaired	JJ	O	impaired	amod	52	SENT_7	[p1l593t2091r874b2160],
52	Treg	NNP	ORGANIZATION	Treg	nsubj	56	SENT_7	[p1l904t2091r1051b2160],
53	resulting	VBG	O	result	partmod	52	SENT_7	[p1l1086t2091r1361b2160],
54	from	IN	O	from	_	0	SENT_7	[p1l1392t2090r1540b2146],
55	sorafenib	NN	O	sorafenib	prep_from	53	SENT_7	[p1l1572t2090r1877b2146],
56	caused	VBD	O	cause	ccomp	49	SENT_7	[p1l1907t2091r2145b2146],
57	the	DT	O	the	det	58	SENT_7	[p1l8t2193r111b2248],
58	psoriasis	NN	O	psoriasis	dobj	56	SENT_7	[p1l141t2193r432b2262],
59	in	IN	O	in	_	0	SENT_7	[p1l462t2193r511b2247],
60	our	PRP$	O	we	poss	61	SENT_7	[p1l542t2207r649b2248],
61	patient	NN	O	patient	prep_in	56	SENT_7	[p1l677t2193r917b2262],
62	.	.	O	.	_	0	SENT_7	[p1l677t2193r917b2262],

1	Interestingly	RB	O	interestingly	advmod	9	SENT_8	[p1l953t2193r1366b2263],
2	,	,	O	,	_	0	SENT_8	[p1l953t2193r1366b2263],
3	a	DT	O	a	det	5	SENT_8	[p1l1399t2207r1436b2248],
4	conflicting	VBG	O	conflict	amod	5	SENT_8	[p1l1464t2192r1801b2263],
5	case	NN	O	case	nsubj	9	SENT_8	[p1l1832t2207r1987b2248],
6	with	IN	O	with	_	0	SENT_8	[p1l2013t2193r2146b2247],
7	recalcitrant	JJ	O	recalcitrant	amod	8	SENT_8	[p1l11t2294r379b2350],
8	psoriasis	NN	O	psoriasis	prep_with	5	SENT_8	[p1l416t2294r706b2363],
9	responded	VBD	O	respond	_	0	SENT_8	[p1l743t2294r1094b2363],
10	well	RB	O	well	advmod	9	SENT_8	[p1l1131t2294r1255b2350],
11	to	TO	O	to	_	0	SENT_8	[p1l1291t2298r1355b2350],
12	sorafenib	NN	O	sorafenib	prep_to	10	SENT_8	[p1l1390t2280r1748b2350],
13	.6	CD	NUMBER	.6	num	12	SENT_8	[p1l1390t2280r1748b2350],
14	The	DT	O	the	det	15	SENT_8	[p1l1780t2294r1903b2350],
15	author	NN	O	author	dobj	9	SENT_8	[p1l1938t2294r2150b2350],
16	suspected	VBN	O	suspect	partmod	15	SENT_8	[p1l9t2397r352b2466],
17	that	IN	O	that	complm	21	SENT_8	[p1l384t2397r511b2452],
18	the	DT	O	the	det	19	SENT_8	[p1l540t2397r643b2452],
19	mechanism	NN	O	mechanism	nsubjpass	21	SENT_8	[p1l676t2397r1053b2452],
20	was	VBD	O	be	auxpass	21	SENT_8	[p1l1085t2410r1217b2452],
21	related	VBN	O	relate	ccomp	16	SENT_8	[p1l1251t2397r1473b2452],
22	to	TO	O	to	_	0	SENT_8	[p1l1504t2400r1568b2452],
23	the	DT	O	the	det	24	SENT_8	[p1l1597t2397r1701b2452],
24	downregulation	NN	O	downregulation	prep_to	21	SENT_8	[p1l1732t2397r2147b2466, p1l8t2498r127b2553],
25	of	IN	O	of	_	0	SENT_8	[p1l165t2497r228b2553],
26	angiogenesis	NN	O	angiogenesis	prep_of	24	SENT_8	[p1l261t2498r697b2568],
27	via	IN	O	via	_	0	SENT_8	[p1l731t2498r823b2553],
28	the	DT	O	the	det	29	SENT_8	[p1l856t2498r959b2553],
29	inhibition	NN	O	inhibition	prep_via	26	SENT_8	[p1l997t2498r1288b2553],
30	of	IN	O	of	_	0	SENT_8	[p1l1326t2497r1389b2553],
31	VEGFR	NNP	LOCATION	VEGFR	prep_of	29	SENT_8	[p1l1420t2497r1678b2563],
32	,	,	O	,	_	0	SENT_8	[p1l1420t2497r1678b2563],
33	PDGFR	NNP	O	PDGFR	prep_of	29	SENT_8	[p1l1721t2497r1965b2553],
34	and	CC	O	and	_	0	SENT_8	[p1l2001t2497r2152b2553],
35	/	:	O	/	punct	38	SENT_8	[p1l2001t2497r2152b2553],
36	or	CC	O	or	dep	38	SENT_8	[p1l10t2614r76b2655],
37	Raf	NN	O	raf	nn	38	SENT_8	[p1l121t2600r314b2655],
38	—	NN	O	—	dep	31	SENT_8	[p1l121t2600r314b2655],
39	1	CD	NUMBER	1	prep_of	29	SENT_8	[p1l121t2600r314b2655],
40	.	.	O	.	_	0	SENT_8	[p1l121t2600r314b2655],

1	Further	JJ	O	further	amod	3	SENT_9	[p1l366t2600r600b2655],
2	molecular	JJ	O	molecular	amod	3	SENT_9	[p1l643t2600r967b2655],
3	investigations	NNS	O	investigation	nsubj	13	SENT_9	[p1l1011t2600r1461b2670],
4	exploring	VBG	O	explore	partmod	3	SENT_9	[p1l1505t2600r1807b2670],
5	the	DT	O	the	det	6	SENT_9	[p1l1851t2600r1954b2655],
6	connection	NN	O	connection	dobj	4	SENT_9	[p1l1999t2614r2147b2655, p1l12t2703r249b2758],
7	between	IN	O	between	_	0	SENT_9	[p1l283t2703r561b2758],
8	sorafenib	NN	O	sorafenib	prep_between	6	SENT_9	[p1l592t2702r897b2758],
9	and	CC	O	and	_	0	SENT_9	[p1l926t2703r1045b2758],
10	psoriasis	NN	O	psoriasis	conj_and	8	SENT_9	[p1l1079t2703r1370b2772],
11	may	MD	O	may	aux	13	SENT_9	[p1l1401t2717r1538b2772],
12	be	VB	O	be	cop	13	SENT_9	[p1l1567t2703r1646b2758],
13	necessary	JJ	O	necessary	_	0	SENT_9	[p1l1677t2717r2028b2772],
14	.	.	O	.	_	0	SENT_9	[p1l1677t2717r2028b2772],

1	Letters	NNS	O	letter	_	0	SENT_10	[p1l1461t2799r1680b2853],
2	to	TO	O	to	_	0	SENT_10	[p1l1713t2810r1776b2853],
3	the	DT	O	the	det	4	SENT_10	[p1l1810t2795r1910b2853],
4	Editor	NNP	O	Editor	prep_to	1	SENT_10	[p1l1941t2795r2153b2853],

1	Chih	NNP	PERSON	Chih	_	0	SENT_11	[p1l436t3022r894b3107],
2	.	.	O	.	_	0	SENT_11	[p1l436t3022r894b3107],

1	—	NN	O	—	_	0	SENT_12	[p1l436t3022r894b3107],
2	.	.	O	.	_	0	SENT_12	[p1l436t3022r894b3107],

1	Tsung	NNP	PERSON	Tsung	nn	2	SENT_13	[p1l436t3022r894b3107],
2	HUNG	NNP	O	HUNG	_	0	SENT_13	[p1l926t3025r1237b3099],
3	,	,	O	,	_	0	SENT_13	[p1l926t3025r1237b3099],
4	Chien	NNP	PERSON	Chien	appos	2	SENT_13	[p1l1278t3022r1713b3107],
5	.	.	O	.	_	0	SENT_13	[p1l1278t3022r1713b3107],

1	—	NN	O	—	_	0	SENT_14	[p1l1278t3022r1713b3107],
2	.	.	O	.	_	0	SENT_14	[p1l1278t3022r1713b3107],

1	Ping	NN	PERSON	ping	nn	3	SENT_15	[p1l1278t3022r1713b3107],
2	CHIAN	NNP	PERSON	CHIAN	nn	3	SENT_15	[p1l1748t3025r2056b3087],
3	G	NNP	PERSON	G	_	0	SENT_15	[p1l2063t3025r2145b3099],
4	,	,	O	,	_	0	SENT_15	[p1l2063t3025r2145b3099],
5	Bai	NNP	PERSON	Bai	appos	3	SENT_15	[p1l1641t3136r1948b3197],
6	.	.	O	.	_	0	SENT_15	[p1l1641t3136r1948b3197],

1	—	NN	O	—	_	0	SENT_16	[p1l1641t3136r1948b3197],
2	.	.	O	.	_	0	SENT_16	[p1l1641t3136r1948b3197],

1	Yao	NNP	ORGANIZATION	Yao	nn	3	SENT_17	[p1l1641t3136r1948b3197],
2	WU	NNP	ORGANIZATION	WU	nn	3	SENT_17	[p1l1984t3137r2151b3198],
3	Department	NNP	ORGANIZATION	Department	_	0	SENT_17	[p1l56t3223r372b3288],
4	of	IN	ORGANIZATION	of	_	0	SENT_17	[p1l398t3220r456b3288],
5	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	3	SENT_17	[p1l468t3220r822b3288],
6	,	,	O	,	_	0	SENT_17	[p1l468t3220r822b3288],
7	Tri-Service	NNP	ORGANIZATION	Tri-Service	nn	9	SENT_17	[p1l862t3222r1146b3272],
8	General	NNP	ORGANIZATION	General	nn	9	SENT_17	[p1l1178t3220r1385b3272],
9	Hospital	NNP	ORGANIZATION	Hospital	appos	5	SENT_17	[p1l1409t3220r1649b3288],
10	,	,	O	,	_	0	SENT_17	[p1l1409t3220r1649b3288],
11	National	NNP	ORGANIZATION	National	nn	14	SENT_17	[p1l1683t3220r1920b3272],
12	Defense	NNP	ORGANIZATION	Defense	nn	14	SENT_17	[p1l1945t3220r2153b3288],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_17	[p1l1265t3313r1474b3365],
14	Center	NNP	ORGANIZATION	Center	appos	5	SENT_17	[p1l1504t3316r1692b3377],
15	,	,	O	,	_	0	SENT_17	[p1l1504t3316r1692b3377],
16	Taipei	NNP	LOCATION	Taipei	appos	5	SENT_17	[p1l1733t3315r1913b3382],
17	,	,	O	,	_	0	SENT_17	[p1l1733t3315r1913b3382],
18	Taiwan	NNP	LOCATION	Taiwan	appos	5	SENT_17	[p1l1953t3315r2152b3365],

1	REFERENCES	NNS	O	reference	_	0	SENT_18	[p1l12t3551r637b3622],

1	1	CD	NUMBER	1	num	3	SENT_19	[p1l11t3723r30b3770],
2	Liu	NNP	ORGANIZATION	Liu	nn	3	SENT_19	[p1l85t3722r163b3771],
3	L	NNP	ORGANIZATION	L	_	0	SENT_19	[p1l206t3722r251b3780],
4	,	,	O	,	_	0	SENT_19	[p1l206t3722r251b3780],
5	Cao	NNP	O	Cao	nn	6	SENT_19	[p1l293t3721r409b3771],
6	Y	NN	O	y	appos	3	SENT_19	[p1l446t3722r501b3780],
7	,	,	O	,	_	0	SENT_19	[p1l446t3722r501b3780],
8	Chen	NNP	PERSON	Chen	nn	9	SENT_19	[p1l544t3721r693b3771],
9	C	NNP	O	C	appos	3	SENT_19	[p1l733t3721r776b3771],
10	et	FW	O	et	nn	11	SENT_19	[p1l848t3725r905b3771],
11	al.	FW	O	al.	dep	9	SENT_19	[p1l938t3722r997b3771],
12	.	.	O	.	_	0	SENT_19	[p1l938t3722r997b3771],

1	Sorafenib	NNP	O	Sorafenib	nsubj	2	SENT_20	[p1l1043t3721r1319b3771],
2	blocks	VBZ	O	block	_	0	SENT_20	[p1l1361t3722r1548b3771],
3	the	DT	O	the	det	4	SENT_20	[p1l1585t3722r1675b3771],
4	RAF/MEK/ERK	NN	O	raf/mek/erk	dobj	2	SENT_20	[p1l1717t3721r2152b3771],

1	pathway	NN	O	pathway	nsubj	8	SENT_21	[p2l84t20r343b81],
2	,	,	O	,	_	0	SENT_21	[p2l84t20r343b81],
3	inhibits	VBZ	O	inhibit	_	0	SENT_21	[p2l373t20r576b68],
4	tumor	NN	O	tumor	nn	5	SENT_21	[p2l599t23r771b68],
5	angiogenesis	NN	O	angiogenesis	dobj	3	SENT_21	[p2l794t20r1192b81],
6	,	,	O	,	_	0	SENT_21	[p2l794t20r1192b81],
7	and	CC	O	and	_	0	SENT_21	[p2l1221t20r1325b68],
8	induces	VBZ	O	induce	conj_and	3	SENT_21	[p2l1355t20r1579b68],
9	tumor	NN	O	tumor	nn	11	SENT_21	[p2l1602t23r1775b68],
10	cell	NN	O	cell	nn	11	SENT_21	[p2l1798t20r1892b68],
11	apoptosis	NN	O	apoptosis	dobj	8	SENT_21	[p2l1919t23r2149b81, p2l81t104r158b152],
12	in	IN	O	in	_	0	SENT_21	[p2l186t104r229b152],
13	hepatocellular	JJ	O	hepatocellular	amod	16	SENT_21	[p2l259t104r668b164],
14	carcinoma	NN	O	carcinoma	nn	16	SENT_21	[p2l692t104r998b152],
15	model	NN	O	model	nn	16	SENT_21	[p2l1025t104r1200b152],
16	PLC/PRF/5	NN	O	plc/prf/5	prep_in	11	SENT_21	[p2l1231t103r1570b153],
17	.	.	O	.	_	0	SENT_21	[p2l1231t103r1570b153],

1	Cancer	NN	O	cancer	_	0	SENT_22	[p2l1623t103r1834b153],
2	Res	NNP	O	Res	dep	1	SENT_22	[p2l1854t104r1964b152],
3	2006	CD	DATE	2006	num	2	SENT_22	[p2l1989t104r2146b161],
4	;	:	O	;	_	0	SENT_22	[p2l1989t104r2146b161],
5	66	CD	NUMBER	66	num	7	SENT_22	[p2l81t188r165b236],
6	:	:	O	:	_	0	SENT_22	[p2l81t188r165b236],
7	11851-11858	CD	NUMBER	11851-11858	dep	1	SENT_22	[p2l198t188r601b236],
8	.	.	O	.	_	0	SENT_22	[p2l198t188r601b236],

1	National	NNP	ORGANIZATION	National	nn	3	SENT_23	[p2l85t272r317b320],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_23	[p2l358t271r567b321],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_23	[p2l607t272r848b320],
4	.	.	O	.	_	0	SENT_23	[p2l607t272r848b320],

1	Common	JJ	O	common	amod	3	SENT_24	[p2l890t271r1155b321],
2	terminology	NN	O	terminology	nn	3	SENT_24	[p2l1193t272r1537b333],
3	criteria	NNS	O	criterion	nsubj	7	SENT_24	[p2l1574t272r1770b320],
4	for	IN	O	for	_	0	SENT_24	[p2l1806t272r1885b320],
5	adverse	JJ	O	adverse	amod	6	SENT_24	[p2l1920t272r2150b320],
6	events	NNS	O	event	prep_for	3	SENT_24	[p2l82t358r271b404],
7	v4	VBP	O	v4	_	0	SENT_24	[p2l302t356r422b404],
8	.0	CD	NUMBER	.0	num	11	SENT_24	[p2l302t356r422b404],
9	(	JJ	O	(	amod	11	SENT_24	[p2l455t355r713b416],
10	CTCAE	NN	O	ctca	nn	11	SENT_24	[p2l455t355r713b416],
11	)	NN	O	)	dobj	7	SENT_24	[p2l455t355r713b416],
12	.	.	O	.	_	0	SENT_24	[p2l455t355r713b416],

1	Available	JJ	O	available	_	0	SENT_25	[p2l746t356r1009b404],
2	at	IN	O	at	prep	1	SENT_25	[p2l1040t358r1107b404],
3	:	:	O	:	_	0	SENT_25	[p2l1040t358r1107b404],
4	http://evs.nci.nih.gov/ftp1/CTCAE/	NN	O	http://evs.nci.nih.gov/ftp1/ctcae/	nn	5	SENT_25	[p2l1144t355r2153b417],
5	CTCAE_4	NN	O	ctcae_4	dep	1	SENT_25	[p2l82t439r1588b500],
6	.03	CD	NUMBER	.03	num	8	SENT_25	[p2l82t439r1588b500],
7	_	NN	O	_	nn	8	SENT_25	[p2l82t439r1588b500],
8	2010-06-14_QuickReference_5x7	NN	O	2010-06-14_quickreference_5x7	dep	5	SENT_25	[p2l82t439r1588b500],
9	.	.	O	.	_	0	SENT_25	[p2l82t439r1588b500],

1	pdf	NN	O	pdf	nsubj	3	SENT_26	[p2l82t439r1588b500],
2	(	CD	NUMBER	(	num	1	SENT_26	[p2l1621t439r1921b500],
3	Accessed	VBN	O	access	_	0	SENT_26	[p2l1621t439r1921b500],
4	February	NNP	DATE	February	tmod	3	SENT_26	[p2l1961t440r2149b488, p2l82t537r170b585],
5	10	CD	DATE	10	num	4	SENT_26	[p2l198t525r278b582],
6	,	,	DATE	,	_	0	SENT_26	[p2l198t525r278b582],
7	2012	CD	DATE	2012	num	4	SENT_26	[p2l306t523r480b585],
8	)	NN	O	)	dep	4	SENT_26	[p2l306t523r480b585],
9	.	.	O	.	_	0	SENT_26	[p2l306t523r480b585],

1	Diamantis	NNP	PERSON	Diamantis	nn	2	SENT_27	[p2l85t608r370b656],
2	ML	NNP	O	ML	_	0	SENT_27	[p2l406t608r508b665],
3	,	,	O	,	_	0	SENT_27	[p2l406t608r508b665],
4	Chon	NNP	PERSON	Chon	nn	5	SENT_27	[p2l546t607r698b657],
5	SY	NNP	PERSON	SY	appos	2	SENT_27	[p2l733t607r828b657],
6	.	.	O	.	_	0	SENT_27	[p2l733t607r828b657],

1	Sorafenib-induced	JJ	O	sorafenib-induced	amod	3	SENT_28	[p2l866t607r1402b657],
2	psoriasiform	NN	O	psoriasiform	nn	3	SENT_28	[p2l1441t608r1795b668],
3	eruption	NN	O	eruption	_	0	SENT_28	[p2l1832t608r2067b668],
4	in	IN	O	in	_	0	SENT_28	[p2l2105t608r2148b656],
5	a	DT	O	a	det	6	SENT_28	[p2l82t704r114b740],
6	patient	NN	O	patient	prep_in	3	SENT_28	[p2l143t692r339b752],
7	with	IN	O	with	_	0	SENT_28	[p2l366t692r482b740],
8	metastatic	JJ	O	metastatic	amod	10	SENT_28	[p2l514t692r814b740],
9	thyroid	NN	O	thyroid	nn	10	SENT_28	[p2l841t692r1039b753],
10	carcinoma	NN	O	carcinoma	prep_with	3	SENT_28	[p2l1069t692r1388b740],
11	.	.	O	.	_	0	SENT_28	[p2l1069t692r1388b740],

1	J	NNP	O	J	nn	3	SENT_29	[p2l1441t692r1476b741],
2	Drugs	NNPS	O	Drugs	nn	3	SENT_29	[p2l1500t692r1671b753],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_29	[p2l1698t692r1965b740],
4	2010	CD	DATE	2010	dep	3	SENT_29	[p2l1989t692r2146b749],
5	;	:	O	;	_	0	SENT_29	[p2l1989t692r2146b749],
6	9	CD	NUMBER	9	num	8	SENT_29	[p2l81t776r129b824],
7	:	:	O	:	_	0	SENT_29	[p2l81t776r129b824],
8	169-171	CD	NUMBER	169-171	dep	3	SENT_29	[p2l162t776r420b824],
9	.	.	O	.	_	0	SENT_29	[p2l162t776r420b824],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_30	[p2l81t860r262b921],
2	K	NNP	PERSON	K	_	0	SENT_30	[p2l294t860r346b917],
3	,	,	O	,	_	0	SENT_30	[p2l294t860r346b917],
4	Li	NNP	PERSON	Li	nn	5	SENT_30	[p2l380t860r421b908],
5	X	NNP	PERSON	X	appos	2	SENT_30	[p2l449t860r502b917],
6	,	,	O	,	_	0	SENT_30	[p2l449t860r502b917],
7	Yin	NNP	O	Yin	nn	8	SENT_30	[p2l532t860r621b908],
8	G	NNP	O	G	appos	2	SENT_30	[p2l651t859r694b909],
9	et	FW	O	et	nn	10	SENT_30	[p2l745t863r802b908],
10	al.	FW	O	al.	dep	8	SENT_30	[p2l824t860r883b908],
11	.	.	O	.	_	0	SENT_30	[p2l824t860r883b908],

1	Functional	JJ	O	functional	amod	2	SENT_31	[p2l920t860r1215b908],
2	characterization	NN	O	characterization	_	0	SENT_31	[p2l1246t860r1708b908],
3	of	IN	O	of	_	0	SENT_31	[p2l1738t860r1793b908],
4	CD4	NN	O	cd4	prep_of	2	SENT_31	[p2l1819t859r2149b909],
5	+	CC	O	+	_	0	SENT_31	[p2l1819t859r2149b909],
6	CD25	NN	O	cd25	nsubj	11	SENT_31	[p2l1819t859r2149b909],
7	+	CC	O	+	_	0	SENT_31	[p2l82t958r116b992],
8	regulatory	JJ	O	regulatory	amod	10	SENT_31	[p2l151t944r441b1005],
9	T	NN	O	t	nn	10	SENT_31	[p2l470t944r508b992],
10	cells	NNS	O	cell	conj_+	6	SENT_31	[p2l538t944r667b993],
11	differentiated	VBN	O	differentiate	rcmod	2	SENT_31	[p2l699t944r1079b993],
12	in	FW	O	in	nn	13	SENT_31	[p2l1115t944r1158b992],
13	vitro	FW	O	vitro	advmod	11	SENT_31	[p2l1191t944r1315b993],
14	from	IN	O	from	_	0	SENT_31	[p2l1346t944r1476b993],
15	bone	NN	O	bone	nn	18	SENT_31	[p2l1512t944r1655b993],
16	marrow-derived	JJ	O	marrow-derived	amod	18	SENT_31	[p2l1689t944r2148b993],
17	haematopoietic	JJ	O	haematopoietic	amod	18	SENT_31	[p2l84t1028r531b1088],
18	cells	NNS	O	cell	prep_from	11	SENT_31	[p2l562t1028r691b1076],
19	of	IN	O	of	_	0	SENT_31	[p2l720t1027r776b1076],
20	psoriasis	NN	O	psoriasis	nn	21	SENT_31	[p2l805t1028r1061b1088],
21	patients	NNS	O	patient	prep_of	18	SENT_31	[p2l1092t1028r1321b1088],
22	with	IN	O	with	_	0	SENT_31	[p2l1350t1028r1466b1076],
23	a	DT	O	a	det	25	SENT_31	[p2l1497t1040r1529b1076],
24	family	NN	O	family	nn	25	SENT_31	[p2l1557t1027r1728b1089],
25	history	NN	O	history	prep_with	21	SENT_31	[p2l1759t1028r1950b1089],
26	of	IN	O	of	_	0	SENT_31	[p2l1979t1027r2034b1076],
27	the	DT	O	the	det	28	SENT_31	[p2l2060t1028r2150b1076],
28	disorder	NN	O	disorder	prep_of	25	SENT_31	[p2l82t1111r335b1160],
29	.	.	O	.	_	0	SENT_31	[p2l82t1111r335b1160],

1	Br	NN	O	br	nn	2	SENT_32	[p2l385t1111r454b1159],
2	J	NN	O	j	_	0	SENT_32	[p2l473t1111r508b1160],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_32	[p2l529t1111r797b1160],
4	2008	CD	DATE	2008	dep	2	SENT_32	[p2l819t1112r976b1169],
5	;	:	O	;	_	0	SENT_32	[p2l819t1112r976b1169],
6	158	CD	NUMBER	158	num	8	SENT_32	[p2l1008t1112r1125b1160],
7	:	:	O	:	_	0	SENT_32	[p2l1008t1112r1125b1160],
8	298-305	CD	NUMBER	298-305	dep	2	SENT_32	[p2l1153t1112r1416b1160],
9	.	.	O	.	_	0	SENT_32	[p2l1153t1112r1416b1160],

1	Desar	JJ	O	desar	amod	2	SENT_33	[p2l85t1196r253b1244],
2	IM	NN	O	im	_	0	SENT_33	[p2l290t1196r373b1253],
3	,	,	O	,	_	0	SENT_33	[p2l290t1196r373b1253],
4	Jacobs	NNP	ORGANIZATION	Jacobs	nn	5	SENT_33	[p2l411t1196r623b1245],
5	JFM	NNP	ORGANIZATION	JFM	appos	2	SENT_33	[p2l659t1196r800b1253],
6	,	,	O	,	_	0	SENT_33	[p2l659t1196r800b1253],
7	Hulsbergen-vandeKaa	NNP	PERSON	Hulsbergen-vandeKaa	nn	8	SENT_33	[p2l843t1196r1493b1257],
8	CA	NNP	O	CA	appos	2	SENT_33	[p2l1530t1195r1617b1245],
9	et	FW	O	et	nn	10	SENT_33	[p2l1682t1199r1738b1244],
10	al.	FW	O	al.	dep	8	SENT_33	[p2l1769t1196r1828b1244],
11	.	.	O	.	_	0	SENT_33	[p2l1769t1196r1828b1244],

1	Sorafenib	NNP	O	Sorafenib	nsubj	2	SENT_34	[p2l1872t1195r2150b1245],
2	reduces	VBZ	O	reduce	_	0	SENT_34	[p2l83t1280r315b1328],
3	the	DT	O	the	det	4	SENT_34	[p2l355t1280r445b1328],
4	percentage	NN	O	percentage	dobj	2	SENT_34	[p2l490t1282r816b1341],
5	of	IN	O	of	_	0	SENT_34	[p2l859t1279r913b1328],
6	tumour	NN	O	tumour	prep_of	4	SENT_34	[p2l951t1282r1160b1328],
7	infiltrating	VBG	O	infiltrate	partmod	6	SENT_34	[p2l1202t1279r1480b1341],
8	regulatory	JJ	O	regulatory	amod	10	SENT_34	[p2l1526t1280r1816b1341],
9	T	NN	O	t	nn	10	SENT_34	[p2l1854t1280r1892b1327],
10	cells	NNS	O	cell	dobj	7	SENT_34	[p2l1932t1280r2061b1328],
11	in	IN	O	in	_	0	SENT_34	[p2l2105t1280r2148b1327],
12	renal	JJ	O	renal	amod	15	SENT_34	[p2l83t1365r219b1413],
13	cell	NN	O	cell	nn	15	SENT_34	[p2l247t1364r341b1413],
14	carcinoma	NN	O	carcinoma	nn	15	SENT_34	[p2l369t1365r674b1413],
15	patients	NNS	O	patient	prep_in	7	SENT_34	[p2l702t1364r946b1425],
16	.	.	O	.	_	0	SENT_34	[p2l702t1364r946b1425],

1	Int	NN	O	int	nn	3	SENT_35	[p2l995t1365r1069b1412],
2	J	NN	O	j	nn	3	SENT_35	[p2l1089t1364r1124b1413],
3	Cancer	NN	O	cancer	_	0	SENT_35	[p2l1149t1364r1360b1413],
4	2011	CD	DATE	2011	dep	3	SENT_35	[p2l1380t1365r1537b1422],
5	;	:	O	;	_	0	SENT_35	[p2l1380t1365r1537b1422],
6	129	CD	NUMBER	129	num	8	SENT_35	[p2l1568t1365r1686b1413],
7	:	:	O	:	_	0	SENT_35	[p2l1568t1365r1686b1413],
8	507-512	CD	NUMBER	507-512	dep	3	SENT_35	[p2l1715t1365r1976b1413],
9	.	.	O	.	_	0	SENT_35	[p2l1715t1365r1976b1413],

1	Fournier	NNP	PERSON	Fournier	nn	2	SENT_36	[p2l85t1448r322b1496],
2	C	NNP	O	C	_	0	SENT_36	[p2l350t1447r408b1505],
3	,	,	O	,	_	0	SENT_36	[p2l350t1447r408b1505],
4	Tisman	NNP	MISC	Tisman	nn	7	SENT_36	[p2l438t1448r648b1496],
5	G.	NNP	MISC	G.	nn	7	SENT_36	[p2l680t1447r740b1497],
6	Sorafenib-associated	JJ	MISC	sorafenib-associated	amod	7	SENT_36	[p2l773t1447r1394b1497],
7	remission	NN	O	remission	appos	2	SENT_36	[p2l1427t1448r1701b1496],
8	of	IN	O	of	_	0	SENT_36	[p2l1733t1448r1789b1496],
9	psoriasis	NN	O	psoriasis	prep_of	7	SENT_36	[p2l1818t1448r2073b1508],
10	in	IN	O	in	_	0	SENT_36	[p2l2105t1448r2148b1496],
11	hypernephroma	NN	O	hypernephroma	prep_in	9	SENT_36	[p2l84t1532r556b1593],
12	:	:	O	:	_	0	SENT_36	[p2l84t1532r556b1593],
13	case	NN	O	case	nn	14	SENT_36	[p2l586t1544r722b1581],
14	report	NN	O	report	dep	2	SENT_36	[p2l749t1535r935b1593],
15	.	.	O	.	_	0	SENT_36	[p2l749t1535r935b1593],

1	Dermatol	NNP	O	Dermatol	nn	3	SENT_37	[p2l985t1532r1251b1581],
2	Online	NNP	O	Online	nn	3	SENT_37	[p2l1275t1531r1456b1581],
3	J	NNP	O	J	_	0	SENT_37	[p2l1480t1532r1516b1581],
4	2010	CD	DATE	2010	num	3	SENT_37	[p2l1539t1533r1696b1589],
5	;	:	O	;	_	0	SENT_37	[p2l1539t1533r1696b1589],
6	16	CD	NUMBER	16	num	8	SENT_37	[p2l1727t1532r1808b1581],
7	:	:	O	:	_	0	SENT_37	[p2l1727t1532r1808b1581],
8	17	CD	NUMBER	17	dep	3	SENT_37	[p2l1841t1533r1921b1580],
9	.	.	O	.	_	0	SENT_37	[p2l1841t1533r1921b1580],

1	Allopurinol-induced	JJ	O	allopurinol-induced	amod	3	SENT_38	[p2l101t1668r720b1728],
2	drug	NN	O	drug	nn	3	SENT_38	[p2l747t1668r888b1729],
3	rash	NN	O	rash	_	0	SENT_38	[p2l918t1668r1050b1717],
4	with	IN	O	with	dep	3	SENT_38	[p2l1075t1668r1206b1716],
5	eosinophilia	NN	O	eosinophilia	nn	8	SENT_38	[p2l1233t1668r1611b1728],
6	and	CC	O	and	_	0	SENT_38	[p2l1638t1668r1750b1717],
7	systemic	JJ	O	systemic	conj_and	5	SENT_38	[p2l1778t1668r2058b1728],
8	symptoms	NNS	O	symptom	pobj	4	SENT_38	[p2l103t1753r431b1810],
9	mimicking	VBG	O	mimic	partmod	8	SENT_38	[p2l459t1750r780b1811],
10	acute	JJ	O	acute	acomp	9	SENT_38	[p2l807t1753r981b1799],
11	generalized	VBN	O	generalize	partmod	8	SENT_38	[p2l1007t1750r1369b1811],
12	exanthematous	JJ	O	exanthematous	amod	13	SENT_38	[p2l1396t1750r1883b1799],
13	pustulosis	NN	O	pustulosis	dobj	11	SENT_38	[p2l15t1857r698b1985],

1	Dear	NNP	O	Dear	nn	2	SENT_39	[p2l12t2145r158b2197],
2	Editor	NNP	O	Editor	nsubjpass	6	SENT_39	[p2l186t2145r382b2206],
3	,	,	O	,	_	0	SENT_39	[p2l186t2145r382b2206],
4	We	PRP	O	we	nsubjpass	6	SENT_39	[p2l8t2240r110b2291],
5	were	VBD	O	be	auxpass	6	SENT_39	[p2l169t2253r320b2291],
6	consulted	VBN	O	consult	_	0	SENT_39	[p2l380t2240r682b2291],
7	for	IN	O	for	_	0	SENT_39	[p2l743t2239r827b2291],
8	a	DT	O	a	det	12	SENT_39	[p2l886t2253r921b2291],
9	65-year-old	JJ	DURATION	65-year-old	amod	12	SENT_39	[p2l980t2240r1339b2305],
10	Han	NNP	MISC	Han	nn	12	SENT_39	[p2l1404t2240r1524b2291],
11	Chinese	NNP	MISC	Chinese	nn	12	SENT_39	[p2l1586t2239r1838b2292],
12	man	NN	O	man	prep_for	6	SENT_39	[p2l1899t2253r2029b2291],
13	presenting	VBG	O	present	partmod	12	SENT_39	[p2l12t2336r337b2401],
14	with	IN	O	with	_	0	SENT_39	[p2l373t2336r498b2387],
15	generalized	VBN	O	generalize	prepc_with	13	SENT_39	[p2l535t2336r891b2401],
16	skin	NN	O	skin	nn	17	SENT_39	[p2l928t2336r1050b2387],
17	eruption	NN	O	eruption	dobj	15	SENT_39	[p2l1087t2336r1340b2401],
18	of	IN	O	of	_	0	SENT_39	[p2l1377t2335r1437b2387],
19	12	CD	DURATION	12	num	20	SENT_39	[p2l1473t2336r1542b2387],
20	days	NNS	NUMBER	day	tmod	21	SENT_39	[p2l1573t2336r1736b2401],
21	’	RB	O	’	amod	22	SENT_39	[p2l1573t2336r1736b2401],
22	duration	NN	O	duration	prep_of	17	SENT_39	[p2l1775t2336r2029b2387],
23	and	CC	O	and	_	0	SENT_39	[p2l10t2433r122b2484],
24	high	JJ	O	high	amod	25	SENT_39	[p2l155t2433r281b2498],
25	fever	NN	O	fever	dobj	15	SENT_39	[p2l311t2432r467b2484],
26	of	IN	O	of	_	0	SENT_39	[p2l493t2432r553b2484],
27	3	CD	DURATION	3	num	28	SENT_39	[p2l579t2433r613b2484],
28	days	NNS	NUMBER	day	prep_of	25	SENT_39	[p2l644t2433r827b2498],
29	’	RB	O	’	advmod	13	SENT_39	[p2l644t2433r827b2498],
30	.	.	O	.	_	0	SENT_39	[p2l644t2433r827b2498],

1	Physical	JJ	O	physical	amod	2	SENT_40	[p2l862t2433r1116b2498],
2	examination	NN	O	examination	nsubj	3	SENT_40	[p2l1147t2433r1524b2484],
3	showed	VBD	O	show	_	0	SENT_40	[p2l1555t2433r1797b2484],
4	generalized	VBN	O	generalize	dep	3	SENT_40	[p2l1828t2446r2030b2498, p2l10t2528r186b2579],
5	follicular	JJ	O	follicular	amod	6	SENT_40	[p2l233t2527r494b2579],
6	pustules	NNS	O	pustule	dobj	4	SENT_40	[p2l540t2528r801b2593],
7	on	IN	O	on	_	0	SENT_40	[p2l847t2541r920b2579],
8	confluent	JJ	O	confluent	amod	13	SENT_40	[p2l968t2527r1258b2579],
9	erythematous	JJ	O	erythematous	amod	13	SENT_40	[p2l1303t2528r1730b2593],
10	macu	NN	O	macu	nn	13	SENT_40	[p2l1778t2528r2030b2579, p2l12t2624r246b2689],
11	|	NN	O	|	nn	13	SENT_40	[p2l1778t2528r2030b2579, p2l12t2624r246b2689],
12	opapular	JJ	O	opapular	amod	13	SENT_40	[p2l1778t2528r2030b2579, p2l12t2624r246b2689],
13	bases	NNS	O	basis	prep_on	6	SENT_40	[p2l319t2624r502b2675],
14	over	IN	O	over	_	0	SENT_40	[p2l575t2637r711b2675],
15	the	DT	O	the	det	23	SENT_40	[p2l780t2624r877b2675],
16	scalp	NN	O	scalp	nn	20	SENT_40	[p2l950t2624r1131b2689],
17	,	,	O	,	_	0	SENT_40	[p2l950t2624r1131b2689],
18	face	NN	O	face	nn	23	SENT_40	[p2l1206t2623r1355b2685],
19	,	,	O	,	_	0	SENT_40	[p2l1206t2623r1355b2685],
20	trunk	NN	O	trunk	nn	23	SENT_40	[p2l1431t2624r1591b2675],
21	and	CC	O	and	_	0	SENT_40	[p2l1662t2624r1775b2675],
22	upper	JJ	O	upper	nn	23	SENT_40	[p2l1852t2637r2033b2689],
23	extremities	NNS	O	extremity	prep_over	4	SENT_40	[p2l10t2720r351b2772],
24	with	IN	O	with	_	0	SENT_40	[p2l416t2720r542b2771],
25	palpable	JJ	O	palpable	amod	26	SENT_40	[p2l613t2720r878b2785],
26	purpura	NN	O	purpura	prep_with	4	SENT_40	[p2l947t2733r1189b2785],
27	over	IN	O	over	_	0	SENT_40	[p2l1255t2733r1391b2772],
28	lower	JJR	O	lower	amod	29	SENT_40	[p2l1457t2720r1625b2772],
29	extremities	NNS	O	extremity	prep_over	26	SENT_40	[p2l1690t2720r2031b2772],
30	(	CD	NUMBER	(	num	31	SENT_40	[p2l10t2815r136b2881],
31	Fig	NN	O	fig	dep	29	SENT_40	[p2l10t2815r136b2881],
32	.	.	O	.	_	0	SENT_40	[p2l10t2815r136b2881],

1	1	CD	NUMBER	1	_	0	SENT_41	[p2l174t2815r239b2881],
2	)	NN	O	)	dep	1	SENT_41	[p2l174t2815r239b2881],
3	.	.	O	.	_	0	SENT_41	[p2l174t2815r239b2881],

1	No	DT	O	no	det	2	SENT_42	[p2l282t2816r366b2867],
2	lymphadenopathy	NN	O	lymphadenopathy	nsubjpass	7	SENT_42	[p2l405t2816r966b2881],
3	or	CC	O	or	_	0	SENT_42	[p2l1001t2829r1063b2867],
4	mucosal	JJ	O	mucosal	amod	5	SENT_42	[p2l1099t2816r1358b2867],
5	lesions	NNS	O	lesion	conj_or	2	SENT_42	[p2l1399t2816r1612b2867],
6	were	VBD	O	be	auxpass	7	SENT_42	[p2l1646t2829r1797b2867],
7	noted	VBN	O	note	_	0	SENT_42	[p2l1836t2816r2027b2867],
8	.	.	O	.	_	0	SENT_42	[p2l1836t2816r2027b2867],

1	According	VBG	O	accord	_	0	SENT_43	[p2l7t2912r326b2978],
2	to	TO	O	to	prepc_according_to	8	SENT_43	[p2l365t2915r425b2964],
3	the	DT	O	the	det	4	SENT_43	[p2l463t2912r560b2964],
4	patient	NN	O	patient	pobj	8	SENT_43	[p2l600t2912r827b2977],
5	,	,	O	,	_	0	SENT_43	[p2l600t2912r827b2977],
6	erythematous	JJ	O	erythematous	amod	7	SENT_43	[p2l870t2912r1297b2977],
7	rashes	NNS	O	rash	nsubj	8	SENT_43	[p2l1338t2912r1542b2964],
8	appeared	VBD	O	appear	_	0	SENT_43	[p2l1581t2912r1876b2977],
9	first	JJ	ORDINAL	first	advmod	12	SENT_43	[p2l1915t2911r2031b2964],
10	then	RB	O	then	advmod	12	SENT_43	[p2l8t3008r142b3060],
11	pustules	NNS	O	pustule	nsubj	12	SENT_43	[p2l182t3008r442b3073],
12	developed	VBD	O	develop	ccomp	8	SENT_43	[p2l478t3008r803b3073],
13	approximately	RB	O	approximately	quantmod	14	SENT_43	[p2l841t3008r1285b3073],
14	10	CD	DATE	10	num	15	SENT_43	[p2l1323t3008r1393b3060],
15	days	NNS	DATE	day	npadvmod	16	SENT_43	[p2l1423t3008r1570b3073],
16	later	RB	DATE	later	advmod	12	SENT_43	[p2l1609t3008r1756b3060],
17	.	.	O	.	_	0	SENT_43	[p2l1609t3008r1756b3060],

1	He	PRP	O	he	nsubj	3	SENT_44	[p2l1798t3008r1880b3060],
2	had	VBD	O	have	aux	3	SENT_44	[p2l1918t3008r2028b3060],
3	received	VBN	O	receive	_	0	SENT_44	[p2l11t3105r272b3156],
4	a	DT	O	a	det	9	SENT_44	[p2l320t3118r355b3156],
5	new	JJ	O	new	amod	9	SENT_44	[p2l401t3118r526b3156],
6	drug	NN	O	drug	nn	9	SENT_44	[p2l570t3105r709b3170],
7	(	NN	O	(	nn	9	SENT_44	[p2l757t3104r1111b3170],
8	allopurinol	NN	O	allopurinol	nn	9	SENT_44	[p2l757t3104r1111b3170],
9	)	NN	O	)	dobj	3	SENT_44	[p2l757t3104r1111b3170],
10	for	IN	O	for	_	0	SENT_44	[p2l1156t3104r1240b3156],
11	hyperuricemia	NN	O	hyperuricemia	prep_for	9	SENT_44	[p2l1285t3105r1726b3170],
12	1	CD	DURATION	1	num	11	SENT_44	[p2l1773t3105r1792b3156],
13	month	NN	NUMBER	month	tmod	3	SENT_44	[p2l1836t3105r2029b3156],
14	before	IN	O	before	mark	18	SENT_44	[p2l12t3199r209b3252],
15	the	DT	O	the	det	17	SENT_44	[p2l239t3200r336b3252],
16	skin	NN	O	skin	nn	17	SENT_44	[p2l368t3200r489b3252],
17	rash	NN	O	rash	nsubj	18	SENT_44	[p2l524t3200r653b3252],
18	developed	VBD	O	develop	advcl	3	SENT_44	[p2l687t3200r1030b3265],
19	.	.	O	.	_	0	SENT_44	[p2l687t3200r1030b3265],

1	Laboratory	NN	O	laboratory	nn	2	SENT_45	[p2l1069t3200r1406b3265],
2	tests	NNS	O	test	nsubj	3	SENT_45	[p2l1435t3203r1586b3252],
3	revealed	VBD	O	reveal	ccomp	24	SENT_45	[p2l1619t3200r1881b3252],
4	leukocytosis	NN	O	leukocytosis	nn	5	SENT_45	[p2l1917t3200r2030b3252, p2l12t3296r305b3362],
5	(	NN	O	(	dobj	3	SENT_45	[p2l373t3295r556b3361],
6	white	JJ	O	white	amod	9	SENT_45	[p2l373t3295r556b3361],
7	blood	NN	O	blood	nn	9	SENT_45	[p2l626t3296r797b3348],
8	cell	NN	O	cell	nn	9	SENT_45	[p2l868t3296r970b3348],
9	count	NN	O	count	tmod	3	SENT_45	[p2l1040t3299r1231b3357],
10	,	,	O	,	_	0	SENT_45	[p2l1040t3299r1231b3357],
11	16	CD	NUMBER	16	num	13	SENT_45	[p2l1307t3297r1377b3348],
12	410/uL	NN	O	410/ul	nn	13	SENT_45	[p2l1406t3295r1639b3361],
13	)	NN	O	)	appos	9	SENT_45	[p2l1406t3295r1639b3361],
14	containing	VBG	O	contain	partmod	13	SENT_45	[p2l1708t3296r2029b3362],
15	marked	JJ	O	marked	amod	16	SENT_45	[p2l11t3392r242b3443],
16	eosinophilia	NN	O	eosinophilia	dobj	14	SENT_45	[p2l282t3392r653b3457],
17	(	CD	NUMBER	(	num	19	SENT_45	[p2l690t3391r995b3457],
18	4759/uL	NN	O	4759/ul	nn	19	SENT_45	[p2l690t3391r995b3457],
19	)	NN	O	)	dep	9	SENT_45	[p2l690t3391r995b3457],
20	,	,	O	,	_	0	SENT_45	[p2l690t3391r995b3457],
21	elevated	JJ	O	elevated	amod	23	SENT_45	[p2l1037t3392r1298b3443],
22	liver	NN	O	liver	nn	23	SENT_45	[p2l1340t3392r1464b3443],
23	enzymes	NNS	O	enzyme	nsubj	24	SENT_45	[p2l1499t3405r1775b3457],
24	(	VBP	O	(	_	0	SENT_45	[p2l1813t3391r2031b3457, p2l8t3491r126b3540],
25	aspartate	NN	O	aspartate	nn	26	SENT_45	[p2l1813t3391r2031b3457, p2l8t3491r126b3540],
26	aminotransferase	NN	O	aminotransferase	dobj	24	SENT_45	[p2l194t3487r752b3549],
27	,	,	O	,	_	0	SENT_45	[p2l194t3487r752b3549],
28	404	CD	NUMBER	404	num	29	SENT_45	[p2l823t3488r936b3540],
29	IU/L	NN	O	iu/l	appos	26	SENT_45	[p2l970t3487r1110b3549],
30	;	:	O	;	_	0	SENT_45	[p2l970t3487r1110b3549],
31	alanine	NN	O	alanine	nn	32	SENT_45	[p2l1182t3488r1402b3540],
32	aminotransferase	NN	O	aminotransferase	dep	26	SENT_45	[p2l1470t3487r2027b3549],
33	,	,	O	,	_	0	SENT_45	[p2l1470t3487r2027b3549],
34	667	CD	NUMBER	667	num	36	SENT_45	[p2l10t3585r122b3636],
35	IU/L	NN	O	iu/l	nn	36	SENT_45	[p2l156t3583r315b3649],
36	)	NN	O	)	appos	32	SENT_45	[p2l156t3583r315b3649],
37	.	.	O	.	_	0	SENT_45	[p2l156t3583r315b3649],

1	A	DT	O	a	det	3	SENT_46	[p2l354t3584r401b3635],
2	skin	NN	O	skin	nn	3	SENT_46	[p2l438t3584r559b3636],
3	biopsy	NN	O	biopsy	nsubj	7	SENT_46	[p2l602t3584r808b3650],
4	of	IN	O	of	_	0	SENT_46	[p2l845t3584r905b3636],
5	the	DT	O	the	det	6	SENT_46	[p2l940t3584r1037b3636],
6	abdomen	NNS	O	abdomen	prep_of	3	SENT_46	[p2l1076t3584r1370b3636],
7	revealed	VBD	O	reveal	_	0	SENT_46	[p2l1413t3584r1674b3636],
8	a	DT	O	a	det	16	SENT_46	[p2l1716t3597r1751b3636],
9	subcor	NN	O	subcor	nn	16	SENT_46	[p2l1789t3584r2030b3636],
10	—	NN	O	—	nn	16	SENT_46	[p2l1789t3584r2030b3636],
11	neal	NN	O	neal	nn	16	SENT_46	[p2l11t3680r152b3741],
12	,	,	O	,	_	0	SENT_46	[p2l11t3680r152b3741],
13	non-spongiform	JJ	O	non-spongiform	amod	16	SENT_46	[p2l205t3679r718b3745],
14	,	,	O	,	_	0	SENT_46	[p2l205t3679r718b3745],
15	neutrophilic	JJ	O	neutrophilic	amod	16	SENT_46	[p2l770t3680r1131b3745],
16	pustule	NN	O	pustule	dobj	7	SENT_46	[p2l1180t3680r1405b3745],
17	over	IN	O	over	_	0	SENT_46	[p2l1451t3693r1587b3731],
18	the	DT	O	the	det	20	SENT_46	[p2l1629t3680r1727b3731],
19	follicular	JJ	O	follicular	amod	20	SENT_46	[p2l1772t3679r2033b3731],
20	opening	NN	O	opening	prep_over	16	SENT_46	[p3l10t23r258b89],
21	with	IN	O	with	_	0	SENT_46	[p3l289t23r414b74],
22	underlying	VBG	O	underlie	amod	23	SENT_46	[p3l449t23r768b89],
23	folliculitis	NN	O	folliculitis	prep_with	7	SENT_46	[p3l799t22r1085b75],
24	and	CC	O	and	_	0	SENT_46	[p3l1116t23r1228b75],
25	perifollicular	JJ	O	perifollicular	amod	26	SENT_46	[p3l1264t22r1641b88],
26	lymphocyte	NN	O	lymphocyte	conj_and	23	SENT_46	[p3l1671t23r2031b88],
27	and	CC	O	and	_	0	SENT_46	[p3l67t417r183b471],
28	eosinophil	NN	O	eosinophil	nn	29	SENT_46	[p3l225t417r549b484],
29	infiltration	NN	O	infiltration	conj_and	23	SENT_46	[p3l593t417r901b471],
30	(	CD	NUMBER	(	num	31	SENT_46	[p3l944t416r1073b485],
31	Fig	NN	O	fig	dep	26	SENT_46	[p3l944t416r1073b485],
32	.	.	O	.	_	0	SENT_46	[p3l944t416r1073b485],

1	2a	NN	O	2a	_	0	SENT_47	[p3l1107t416r1282b484],
2	,	,	O	,	_	0	SENT_47	[p3l1107t416r1282b484],
3	b	NN	O	b	nn	4	SENT_47	[p3l1107t416r1282b484],
4	)	NN	O	)	appos	1	SENT_47	[p3l1107t416r1282b484],
5	.	.	O	.	_	0	SENT_47	[p3l1107t416r1282b484],

1	Another	DT	O	another	det	2	SENT_48	[p3l1323t417r1579b471],
2	biopsy	NN	O	biopsy	nsubj	6	SENT_48	[p3l1618t417r1830b485],
3	from	IN	O	from	_	0	SENT_48	[p3l1866t417r2011b471],
4	the	DT	O	the	det	5	SENT_48	[p3l2051t417r2151b471],
5	leg	NN	O	leg	prep_from	2	SENT_48	[p3l69t517r157b584],
6	showed	VBD	O	show	_	0	SENT_48	[p3l193t517r443b570],
7	lymphooytic	JJ	O	lymphooytic	amod	8	SENT_48	[p3l482t517r868b584],
8	vasculitis	NN	O	vasculitis	dobj	6	SENT_48	[p3l901t517r1198b570],
9	with	IN	O	with	_	0	SENT_48	[p3l1230t517r1359b569],
10	red	JJ	O	red	amod	13	SENT_48	[p3l1397t517r1495b570],
11	blood	NN	O	blood	nn	13	SENT_48	[p3l1534t517r1711b570],
12	cell	NN	O	cell	nn	13	SENT_48	[p3l1748t517r1851b570],
13	extravasation	NN	O	extravasation	prep_with	6	SENT_48	[p3l1887t519r2150b570, p3l66t615r257b668],
14	in	IN	O	in	_	0	SENT_48	[p3l312t615r360b668],
15	the	DT	O	the	det	19	SENT_48	[p3l411t615r512b668],
16	superficial	JJ	O	superficial	amod	19	SENT_48	[p3l563t614r889b682],
17	dermis	NN	O	dermi	nn	19	SENT_48	[p3l942t615r1159b668],
18	(	CD	NUMBER	(	num	19	SENT_48	[p3l1211t614r1341b682],
19	Fig	NN	O	fig	prep_in	6	SENT_48	[p3l1211t614r1341b682],
20	.	.	O	.	_	0	SENT_48	[p3l1211t614r1341b682],

1	2c	NN	O	2c	_	0	SENT_49	[p3l1375t614r1550b682],
2	,	,	O	,	_	0	SENT_49	[p3l1375t614r1550b682],
3	d	NN	O	d	nn	4	SENT_49	[p3l1375t614r1550b682],
4	)	NN	O	)	appos	1	SENT_49	[p3l1375t614r1550b682],
5	.	.	O	.	_	0	SENT_49	[p3l1375t614r1550b682],

1	The	DT	O	the	det	4	SENT_50	[p3l1603t615r1723b668],
2	subsequent	JJ	O	subsequent	amod	4	SENT_50	[p3l1774t615r2152b682],
3	laboratory	NN	O	laboratory	nn	4	SENT_50	[p3l69t715r393b782],
4	test	NN	O	test	nsubj	5	SENT_50	[p3l430t717r550b768],
5	showed	VBD	O	show	_	0	SENT_50	[p3l590t715r840b768],
6	positive	JJ	O	positive	amod	7	SENT_50	[p3l885t715r1131b782],
7	HLA-B	NN	O	hla-b	dobj	5	SENT_50	[p3l1169t715r1567b768],
8	*	CD	NUMBER	*	number	9	SENT_50	[p3l1169t715r1567b768],
9	5801	CD	NUMBER	5801	num	10	SENT_50	[p3l1169t715r1567b768],
10	genotype	NN	O	genotype	dep	5	SENT_50	[p3l1613t717r1930b782],
11	.	.	O	.	_	0	SENT_50	[p3l1613t717r1930b782],

1	Serological	JJ	O	serological	amod	2	SENT_51	[p3l1975t713r2150b768, p3l69t814r270b881],
2	tests	NNS	O	test	_	0	SENT_51	[p3l306t816r461b867],
3	for	IN	O	for	_	0	SENT_51	[p3l494t813r581b867],
4	viral	JJ	O	viral	amod	5	SENT_51	[p3l612t814r739b867],
5	infections	NNS	O	infection	prep_for	2	SENT_51	[p3l779t813r1086b867],
6	including	VBG	O	include	_	0	SENT_51	[p3l1123t814r1406b881],
7	hepatitis	NN	O	hepatitis	nn	8	SENT_51	[p3l1445t814r1715b880],
8	A	NN	O	a	prep_including	5	SENT_51	[p3l1747t814r1809b877],
9	,	,	O	,	_	0	SENT_51	[p3l1747t814r1809b877],
10	B	NN	O	b	appos	8	SENT_51	[p3l1851t814r1893b866],
11	and	CC	O	and	_	0	SENT_51	[p3l1929t814r2045b867],
12	C	NN	O	c	conj_and	10	SENT_51	[p3l2083t812r2147b877],
13	,	,	O	,	_	0	SENT_51	[p3l2083t812r2147b877],
14	Epstein	NN	PERSON	epstein	appos	10	SENT_51	[p3l70t912r482b979],
15	.	.	O	.	_	0	SENT_51	[p3l70t912r482b979],

1	—	NN	O	—	_	0	SENT_52	[p3l70t912r482b979],
2	.	.	O	.	_	0	SENT_52	[p3l70t912r482b979],

1	Barr	NN	O	barr	nn	2	SENT_53	[p3l70t912r482b979],
2	virus	NN	O	virus	nsubj	6	SENT_53	[p3l513t912r664b965],
3	and	CC	O	and	_	0	SENT_53	[p3l698t912r814b965],
4	cytomegalovirus	NN	O	cytomegalovirus	nsubj	6	SENT_53	[p3l852t912r1381b979],
5	were	VBD	O	be	cop	6	SENT_53	[p3l1415t925r1570b965],
6	negative	JJ	O	negative	_	0	SENT_53	[p3l1607t912r1893b979],
7	.	.	O	.	_	0	SENT_53	[p3l1607t912r1893b979],

1	Survey	NN	O	survey	nsubj	20	SENT_54	[p3l1932t911r2153b979],
2	of	IN	O	of	_	0	SENT_54	[p3l67t1010r128b1064],
3	systemic	JJ	O	systemic	amod	4	SENT_54	[p3l165t1011r450b1078],
4	vasculitis	NN	O	vasculitis	prep_of	1	SENT_54	[p3l488t1011r784b1064],
5	including	VBG	O	include	_	0	SENT_54	[p3l826t1011r1110b1079],
6	antinuclear	JJ	O	antinuclear	amod	7	SENT_54	[p3l1151t1011r1506b1064],
7	antibody	NN	O	antibody	prep_including	4	SENT_54	[p3l1543t1011r1838b1078],
8	,	,	O	,	_	0	SENT_54	[p3l1543t1011r1838b1078],
9	rheumatoid	JJ	O	rheumatoid	amod	10	SENT_54	[p3l1884t1011r2151b1064, p3l65t1110r184b1163],
10	factor	NN	O	factor	prep_including	4	SENT_54	[p3l225t1109r428b1173],
11	,	,	O	,	_	0	SENT_54	[p3l225t1109r428b1173],
12	antineutrophil	JJ	O	antineutrophil	amod	14	SENT_54	[p3l473t1110r908b1177],
13	cytoplasmic	JJ	O	cytoplasmic	amod	14	SENT_54	[p3l950t1110r1339b1177],
14	antibodies	NNS	O	antibody	prep_including	4	SENT_54	[p3l1380t1110r1729b1173],
15	,	,	O	,	_	0	SENT_54	[p3l1380t1110r1729b1173],
16	C3	NN	O	c3	prep_including	4	SENT_54	[p3l1775t1109r1862b1164],
17	and	CC	O	and	_	0	SENT_54	[p3l1904t1110r2020b1163],
18	C4	NN	O	c4	conj_and	7	SENT_54	[p3l2063t1109r2151b1164],
19	were	VBD	O	be	cop	20	SENT_54	[p3l65t1222r221b1262],
20	negative	JJ	O	negative	_	0	SENT_54	[p3l259t1209r544b1276],
21	.	.	O	.	_	0	SENT_54	[p3l259t1209r544b1276],

1	Bacterial	JJ	O	bacterial	amod	2	SENT_55	[p3l587t1209r864b1262],
2	cultures	NNS	O	culture	nsubj	7	SENT_55	[p3l902t1209r1157b1262],
3	of	IN	O	of	_	0	SENT_55	[p3l1192t1208r1254b1262],
4	blood	NN	O	blood	prep_of	2	SENT_55	[p3l1289t1209r1466b1262],
5	were	VBD	O	be	cop	7	SENT_55	[p3l1504t1222r1659b1262],
6	also	RB	O	also	advmod	7	SENT_55	[p3l1695t1209r1824b1262],
7	negative	JJ	O	negative	_	0	SENT_55	[p3l1862t1209r2147b1276],
8	.	.	O	.	_	0	SENT_55	[p3l1862t1209r2147b1276],

1	The	DT	O	the	det	2	SENT_56	[p3l64t1308r184b1361],
2	diagnosis	NN	O	diagnosis	nsubj	11	SENT_56	[p3l235t1308r541b1376],
3	of	IN	O	of	_	0	SENT_56	[p3l592t1307r653b1361],
4	drug	NN	O	drug	nn	5	SENT_56	[p3l701t1308r844b1376],
5	rash	NN	O	rash	prep_of	2	SENT_56	[p3l899t1308r1032b1361],
6	with	IN	O	with	_	0	SENT_56	[p3l1083t1308r1212b1361],
7	eosinophilia	NN	O	eosinophilia	nn	10	SENT_56	[p3l1265t1308r1647b1375],
8	and	CC	O	and	_	0	SENT_56	[p3l1697t1308r1813b1361],
9	systemic	JJ	O	systemic	nn	10	SENT_56	[p3l1866t1308r2150b1375],
10	symptoms	NNS	O	symptom	prep_with	5	SENT_56	[p3l66t1410r404b1474],
11	(	VBP	O	(	_	0	SENT_56	[p3l433t1406r705b1474],
12	DRESS	NN	O	dress	nn	13	SENT_56	[p3l433t1406r705b1474],
13	)	NN	O	)	nsubjpass	15	SENT_56	[p3l433t1406r705b1474],
14	was	VBD	O	be	auxpass	15	SENT_56	[p3l734t1420r862b1460],
15	made	VBN	O	make	ccomp	11	SENT_56	[p3l892t1407r1087b1460],
16	.	.	O	.	_	0	SENT_56	[p3l892t1407r1087b1460],

1	After	IN	O	after	_	0	SENT_57	[p3l1116t1406r1271b1460],
2	treatment	NN	O	treatment	prep_after	13	SENT_57	[p3l1295t1410r1607b1460],
3	with	IN	O	with	_	0	SENT_57	[p3l1634t1407r1763b1460],
4	i.v.	NN	O	i.v.	nn	5	SENT_57	[p3l1796t1407r1878b1460],
5	methylprednisolone	NN	O	methylprednisolone	prep_with	2	SENT_57	[p3l1912t1407r2150b1474, p3l69t1506r484b1573],
6	(	CD	NUMBER	(	number	7	SENT_57	[p3l537t1505r631b1573],
7	80	CD	NUMBER	80	dep	5	SENT_57	[p3l537t1505r631b1573],
8	mg/day	JJ	O	mg/day	amod	9	SENT_57	[p3l665t1505r941b1573],
9	)	NN	O	)	dep	7	SENT_57	[p3l665t1505r941b1573],
10	,	,	O	,	_	0	SENT_57	[p3l665t1505r941b1573],
11	his	PRP$	O	he	poss	12	SENT_57	[p3l999t1506r1086b1559],
12	fever	NN	O	fever	nsubj	13	SENT_57	[p3l1136t1505r1297b1559],
13	subsided	VBD	O	subside	_	0	SENT_57	[p3l1347t1506r1638b1559],
14	and	CC	O	and	_	0	SENT_57	[p3l1693t1506r1809b1559],
15	the	DT	O	the	det	16	SENT_57	[p3l1862t1506r1962b1559],
16	rash	NN	O	rash	nsubj	17	SENT_57	[p3l2017t1506r2149b1559],
17	improved	VBD	O	improve	conj_and	13	SENT_57	[p3l69t1605r367b1672],
18	gradually	RB	O	gradually	advmod	17	SENT_57	[p3l400t1605r709b1673],
19	.	.	O	.	_	0	SENT_57	[p3l400t1605r709b1673],

1	The	DT	O	the	det	2	SENT_58	[p3l742t1605r861b1658],
2	pustules	NNS	O	pustule	nsubj	3	SENT_58	[p3l894t1605r1163b1672],
3	regressed	VBD	O	regress	_	0	SENT_58	[p3l1195t1605r1512b1673],
4	and	CC	O	and	_	0	SENT_58	[p3l1546t1605r1662b1658],
5	were	VBD	O	be	auxpass	6	SENT_58	[p3l1694t1618r1850b1658],
6	followed	VBN	O	follow	conj_and	3	SENT_58	[p3l1879t1604r2149b1658],
7	by	IN	O	by	_	0	SENT_58	[p3l69t1704r143b1771],
8	desquamation	NN	O	desquamation	agent	6	SENT_58	[p3l172t1704r648b1771],
9	.	.	O	.	_	0	SENT_58	[p3l172t1704r648b1771],

1	However	RB	O	however	advmod	8	SENT_59	[p3l685t1704r983b1767],
2	,	,	O	,	_	0	SENT_59	[p3l685t1704r983b1767],
3	acute	JJ	O	acute	amod	5	SENT_59	[p3l1016t1707r1194b1757],
4	renal	JJ	O	renal	amod	5	SENT_59	[p3l1225t1704r1376b1757],
5	failure	NN	O	failure	nsubj	8	SENT_59	[p3l1406t1703r1600b1757],
6	and	CC	O	and	_	0	SENT_59	[p3l1629t1704r1746b1757],
7	myocarditis	NN	O	myocarditis	conj_and	5	SENT_59	[p3l1780t1704r2151b1771],
8	occurred	VBD	O	occur	_	0	SENT_59	[p3l67t1803r352b1856],
9	after	IN	O	after	_	0	SENT_59	[p3l402t1802r547b1856],
10	tapering	VBG	O	taper	prepc_after	8	SENT_59	[p3l590t1803r853b1871],
11	corticosteroids	NNS	O	corticosteroid	dobj	10	SENT_59	[p3l902t1803r1399b1856],
12	.	.	O	.	_	0	SENT_59	[p3l902t1803r1399b1856],

1	Fever	NN	O	fever	nn	4	SENT_60	[p3l1453t1803r1630b1856],
2	and	CC	O	and	_	0	SENT_60	[p3l1675t1803r1791b1856],
3	skin	NN	O	skin	nn	4	SENT_60	[p3l1841t1803r1965b1856],
4	rash	NN	O	rash	nsubj	5	SENT_60	[p3l2017t1803r2149b1856],
5	waxed	VBD	O	wax	_	0	SENT_60	[p3l66t1902r275b1955],
6	and	CC	O	and	_	0	SENT_60	[p3l308t1902r424b1955],
7	waned	VBD	O	wane	conj_and	5	SENT_60	[p3l455t1902r667b1955],
8	during	IN	O	during	_	0	SENT_60	[p3l699t1902r899b1970],
9	hospitalization	NN	O	hospitalization	prep_during	5	SENT_60	[p3l932t1902r1408b1969],
10	.	.	O	.	_	0	SENT_60	[p3l932t1902r1408b1969],

1	After	IN	O	after	_	0	SENT_61	[p3l1440t1901r1595b1955],
2	3	CD	DURATION	3	num	3	SENT_61	[p3l1622t1902r1658b1955],
3	months	NNS	NUMBER	month	tmod	4	SENT_61	[p3l1691t1902r1945b1955],
4	’	JJ	O	’	amod	5	SENT_61	[p3l1691t1902r1945b1955],
5	treatment	NN	O	treatment	prep_after	10	SENT_61	[p3l1977t1905r2150b1955, p3l69t2005r244b2065],
6	,	,	O	,	_	0	SENT_61	[p3l1977t1905r2150b1955, p3l69t2005r244b2065],
7	he	PRP	O	he	nsubjpass	10	SENT_61	[p3l307t2002r381b2055],
8	was	VBD	O	be	auxpass	10	SENT_61	[p3l436t2015r564b2055],
9	finally	RB	O	finally	advmod	10	SENT_61	[p3l620t2001r805b2069],
10	discharged	VBN	O	discharge	_	0	SENT_61	[p3l860t2002r1217b2069],
11	after	IN	O	after	mark	15	SENT_61	[p3l1276t2001r1422b2055],
12	the	DT	O	the	det	14	SENT_61	[p3l1474t2002r1574b2055],
13	visceral	JJ	O	visceral	amod	14	SENT_61	[p3l1630t2002r1872b2055],
14	organs	NNS	O	organ	nsubj	15	SENT_61	[p3l1931t2015r2151b2069],
15	recovered	VBD	O	recover	advcl	10	SENT_61	[p3l68t2083r407b2137],
16	.	.	O	.	_	0	SENT_61	[p3l68t2083r407b2137],

1	CorrespondenceCorrespondence	NNP	O	CorrespondenceCorrespondence	_	0	SENT_62	[p3l90t2323r535b2354],
2	:	:	O	:	_	0	SENT_62	[p3l90t2323r535b2354],
3	Ying	NNP	O	Ying	dep	1	SENT_62	[p3l556t2324r666b2354],
4	.	.	O	.	_	0	SENT_62	[p3l556t2324r666b2354],

1	—	NN	O	—	_	0	SENT_63	[p3l556t2324r666b2354],
2	.	.	O	.	_	0	SENT_63	[p3l556t2324r666b2354],

1	Yi	NNP	PERSON	Yi	nn	2	SENT_64	[p3l556t2324r666b2354],
2	Chiang	NNP	PERSON	Chiang	_	0	SENT_64	[p3l687t2323r788b2354],
3	,	,	O	,	_	0	SENT_64	[p3l687t2323r788b2354],
4	M.D.	NNP	O	M.D.	appos	2	SENT_64	[p3l809t2324r888b2351],
5	,	,	O	,	_	0	SENT_64	[p3l809t2324r888b2351],
6	Department	NNP	ORGANIZATION	Department	appos	2	SENT_64	[p3l909t2324r1067b2354],
7	of	IN	ORGANIZATION	of	_	0	SENT_64	[p3l1087t2323r1116b2347],
8	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	6	SENT_64	[p3l1131t2323r1310b2354],
9	,	,	ORGANIZATION	,	_	0	SENT_64	[p3l1131t2323r1310b2354],
10	Wan	NNP	ORGANIZATION	Wan	nn	12	SENT_64	[p3l1331t2325r1394b2347],
11	Fang	NNP	ORGANIZATION	Fang	nn	12	SENT_64	[p3l1415t2325r1478b2354],
12	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_64	[p3l1496t2323r1612b2354],
13	,	,	O	,	_	0	SENT_64	[p3l1496t2323r1612b2354],
14	Taipei	NNP	ORGANIZATION	Taipei	nn	16	SENT_64	[p3l1634t2324r1716b2354],
15	Medical	NNP	ORGANIZATION	Medical	nn	16	SENT_64	[p3l1736t2323r1841b2347],
16	University	NNP	ORGANIZATION	University	appos	2	SENT_64	[p3l1860t2324r2003b2354],
17	,	,	O	,	_	0	SENT_64	[p3l1860t2324r2003b2354],
18	111	CD	NUMBER	111	num	19	SENT_64	[p3l2027t2324r2070b2346],
19	Hsing	NN	O	hsing	appos	2	SENT_64	[p3l89t2362r248b2391],
20	.	.	O	.	_	0	SENT_64	[p3l89t2362r248b2391],

1	—	NN	O	—	_	0	SENT_65	[p3l89t2362r248b2391],
2	.	.	O	.	_	0	SENT_65	[p3l89t2362r248b2391],

1	Long	JJ	LOCATION	long	_	0	SENT_66	[p3l89t2362r248b2391],
2	Road	NNP	LOCATION	Road	nn	3	SENT_66	[p3l259t2361r332b2384],
3	Sec	NNP	LOCATION	Sec	dep	1	SENT_66	[p3l344t2362r394b2384],
4	.	.	O	.	_	0	SENT_66	[p3l344t2362r394b2384],

1	3	CD	NUMBER	3	_	0	SENT_67	[p3l408t2362r430b2388],
2	,	,	O	,	_	0	SENT_67	[p3l408t2362r430b2388],
3	Wenshan	NNP	LOCATION	Wenshan	nn	7	SENT_67	[p3l443t2361r566b2384],
4	District	NNP	LOCATION	District	nn	7	SENT_67	[p3l577t2362r681b2388],
5	,	,	O	,	_	0	SENT_67	[p3l577t2362r681b2388],
6	Taipei	NNP	LOCATION	Taipei	appos	7	SENT_67	[p3l694t2362r777b2391],
7	City	NNP	LOCATION	City	appos	1	SENT_67	[p3l790t2362r847b2391],
8	116	CD	NUMBER	116	num	7	SENT_67	[p3l860t2362r913b2388],
9	,	,	O	,	_	0	SENT_67	[p3l860t2362r913b2388],
10	Taiwan	NNP	LOCATION	Taiwan	appos	7	SENT_67	[p3l927t2362r1031b2384],
11	.	.	O	.	_	0	SENT_67	[p3l927t2362r1031b2384],

1	Email	VB	O	email	_	0	SENT_68	[p3l1045t2361r1126b2384],
2	:	:	O	:	_	0	SENT_68	[p3l1045t2361r1126b2384],
3	ellychiang@hotmail.com	NNP	O	ellychiang@hotmail.com	nn	5	SENT_68	[p3l1141t2360r1469b2391],
4	Financial	NNP	O	Financial	nn	5	SENT_68	[p3l90t2397r206b2420],
5	disclosure	NN	O	disclosure	dobj	1	SENT_68	[p3l218t2397r351b2420],
6	:	:	O	:	_	0	SENT_68	[p3l218t2397r351b2420],
7	none	NN	O	none	dep	1	SENT_68	[p3l365t2406r436b2420],
8	.	.	O	.	_	0	SENT_68	[p3l365t2406r436b2420],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_69	[p3l90t2434r197b2457],
2	of	IN	O	of	_	0	SENT_69	[p3l209t2434r238b2457],
3	interest	NN	O	interest	prep_of	1	SENT_69	[p3l245t2435r346b2457],
4	:	:	O	:	_	0	SENT_69	[p3l245t2435r346b2457],
5	none	NN	O	none	dep	1	SENT_69	[p3l361t2443r432b2457],
6	.	.	O	.	_	0	SENT_69	[p3l361t2443r432b2457],

1	©	RB	O	©	dep	2	SENT_70	[p3l89t2528r119b2557],
2	2012	CD	DATE	2012	dep	5	SENT_70	[p3l134t2529r213b2557],
3	Japanese	JJ	MISC	japanese	amod	5	SENT_70	[p3l224t2530r364b2566],
4	Dermatological	NNP	O	Dermatological	nn	5	SENT_70	[p3l380t2528r632b2566],
5	Association	NNP	O	Association	_	0	SENT_70	[p3l646t2529r832b2557],
6	1077	CD	DATE	1077	dep	5	SENT_70	[p3l1993t2529r2071b2557],

1	Letters	NNS	O	letter	_	0	SENT_71	[p3l8t2739r227b2793],
2	to	TO	O	to	_	0	SENT_71	[p3l260t2750r323b2793],
3	the	DT	O	the	det	4	SENT_71	[p3l356t2735r457b2793],
4	Editor	NNP	O	Editor	prep_to	1	SENT_71	[p3l488t2735r699b2793],

1	Figure	NNP	O	Figure	_	0	SENT_72	[p4l11t1731r231b1800],
2	1	CD	NUMBER	1	dep	1	SENT_72	[p4l265t1732r318b1785],
3	.	.	O	.	_	0	SENT_72	[p4l265t1732r318b1785],

1	Clinical	JJ	O	clinical	amod	2	SENT_73	[p4l367t1730r602b1787],
2	manifestation	NN	O	manifestation	_	0	SENT_73	[p4l647t1731r1088b1786],
3	of	IN	O	of	_	0	SENT_73	[p4l1132t1731r1195b1786],
4	the	DT	O	the	det	5	SENT_73	[p4l1232t1731r1335b1786],
5	patient	NN	O	patient	prep_of	2	SENT_73	[p4l1379t1731r1603b1800],
6	with	IN	O	with	_	0	SENT_73	[p4l1643t1731r1776b1785],
7	drug	NN	O	drug	nn	8	SENT_73	[p4l1820t1731r1967b1801],
8	rash	NN	O	rash	prep_with	5	SENT_73	[p4l2012t1731r2149b1786],
9	with	IN	O	with	_	0	SENT_73	[p4l8t1826r140b1880],
10	eosinophilia	NN	O	eosinophilia	nn	13	SENT_73	[p4l179t1826r573b1895],
11	and	CC	O	and	_	0	SENT_73	[p4l608t1826r728b1881],
12	systemic	JJ	O	systemic	conj_and	10	SENT_73	[p4l768t1826r1060b1895],
13	symptoms	NNS	O	symptom	prep_with	2	SENT_73	[p4l1097t1828r1461b1895],
14	.	.	O	.	_	0	SENT_73	[p4l1097t1828r1461b1895],

1	(	NN	O	(	nsubj	4	SENT_74	[p4l1502t1824r1575b1895],
2	a	DT	O	a	det	4	SENT_74	[p4l1502t1824r1575b1895],
3	)	CD	NUMBER	)	num	4	SENT_74	[p4l1502t1824r1575b1895],
4	Generalized	NNP	O	Generalized	_	0	SENT_74	[p4l1615t1824r2005b1881],
5	follicular	JJ	O	follicular	amod	6	SENT_74	[p4l2042t1825r2149b1881, p4l11t1918r203b1973],
6	pustules	NNS	O	pustule	dobj	4	SENT_74	[p4l238t1918r514b1987],
7	on	IN	O	on	_	0	SENT_74	[p4l548t1932r626b1973],
8	erythematous	JJ	O	erythematous	amod	10	SENT_74	[p4l663t1918r1116b1988],
9	maculopapular	JJ	O	maculopapular	amod	10	SENT_74	[p4l1153t1918r1647b1987],
10	base	NN	O	base	prep_on	6	SENT_74	[p4l1682t1918r1838b1973],
11	over	IN	O	over	_	0	SENT_74	[p4l1873t1932r2017b1973],
12	the	DT	O	the	det	13	SENT_74	[p4l2047t1918r2151b1973],
13	face	NN	O	face	prep_over	4	SENT_74	[p4l7t2011r148b2067],
14	and	CC	O	and	_	0	SENT_74	[p4l181t2011r301b2067],
15	neck	NN	O	neck	conj_and	13	SENT_74	[p4l338t2011r510b2067],
16	.	.	O	.	_	0	SENT_74	[p4l338t2011r510b2067],

1	(	NN	O	(	nn	2	SENT_75	[p4l548t2010r625b2080],
2	b	NN	O	b	nsubj	9	SENT_75	[p4l548t2010r625b2080],
3	)	CD	NUMBER	)	num	5	SENT_75	[p4l548t2010r625b2080],
4	Close-up	NN	MISC	close-up	nn	5	SENT_75	[p4l660t2010r961b2080],
5	view	NN	O	view	dep	2	SENT_75	[p4l992t2011r1141b2067],
6	of	IN	O	of	_	0	SENT_75	[p4l1173t2011r1237b2067],
7	the	DT	O	the	det	8	SENT_75	[p4l1265t2011r1369b2067],
8	back	NN	O	back	prep_of	2	SENT_75	[p4l1404t2011r1563b2067],
9	showed	VBD	O	show	_	0	SENT_75	[p4l1594t2011r1852b2067],
10	discrete	JJ	O	discrete	amod	12	SENT_75	[p4l1887t2011r2151b2067],
11	follicular	JJ	O	follicular	amod	12	SENT_75	[p4l7t2104r285b2160],
12	pustules	NNS	O	pustule	dobj	9	SENT_75	[p4l337t2105r630b2174],
13	.	.	O	.	_	0	SENT_75	[p4l337t2105r630b2174],

1	(	NN	O	(	nn	2	SENT_76	[p4l688t2103r761b2174],
2	c	NN	O	c	_	0	SENT_76	[p4l688t2103r761b2174],
3	)	CD	NUMBER	)	num	5	SENT_76	[p4l688t2103r761b2174],
4	Palpable	JJ	O	palpable	amod	5	SENT_76	[p4l818t2105r1103b2174],
5	purpura	NN	O	purpura	dep	2	SENT_76	[p4l1158t2119r1414b2174],
6	over	IN	O	over	_	0	SENT_76	[p4l1466t2119r1610b2160],
7	bilateral	JJ	O	bilateral	amod	9	SENT_76	[p4l1663t2105r1917b2160],
8	lower	JJR	O	lower	amod	9	SENT_76	[p4l1976t2105r2153b2160],
9	extremities	NNS	O	extremity	prep_over	5	SENT_76	[p4l9t2196r387b2251],
10	.	.	O	.	_	0	SENT_76	[p4l9t2196r387b2251],

1	Figure	NN	O	figure	_	0	SENT_77	[p5l11t898r231b967],
2	2	CD	NUMBER	2	dep	1	SENT_77	[p5l261t898r318b952],
3	.	.	O	.	_	0	SENT_77	[p5l261t898r318b952],

1	Histological	JJ	O	histological	amod	2	SENT_78	[p5l370t898r749b968],
2	findings	NNS	O	finding	_	0	SENT_78	[p5l778t898r1039b968],
3	of	IN	O	of	_	0	SENT_78	[p5l1067t898r1130b953],
4	skin	NN	O	skin	nn	5	SENT_78	[p5l1155t898r1284b953],
5	biopsies	NNS	O	biopsy	prep_of	2	SENT_78	[p5l1317t898r1590b967],
6	of	IN	O	of	_	0	SENT_78	[p5l1618t898r1681b953],
7	the	DT	O	the	det	8	SENT_78	[p5l1705t898r1808b953],
8	abdomen	NN	O	abdomen	prep_of	2	SENT_78	[p5l1837t898r2149b953],
9	and	CC	O	and	_	0	SENT_78	[p5l9t992r128b1047],
10	leg	NN	O	leg	conj_and	8	SENT_78	[p5l165t992r274b1062],
11	.	.	O	.	_	0	SENT_78	[p5l165t992r274b1062],

1	(	NN	O	(	nsubj	9	SENT_79	[p5l310t991r383b1061],
2	a	DT	O	a	det	5	SENT_79	[p5l310t991r383b1061],
3	)	NN	O	)	nn	5	SENT_79	[p5l310t991r383b1061],
4	Skin	NN	O	skin	nn	5	SENT_79	[p5l416t991r555b1048],
5	biopsy	NN	O	biopsy	dep	1	SENT_79	[p5l590t992r808b1062],
6	of	IN	O	of	_	0	SENT_79	[p5l837t992r901b1047],
7	the	DT	O	the	det	8	SENT_79	[p5l927t992r1030b1047],
8	abdomen	NNS	O	abdomen	prep_of	1	SENT_79	[p5l1061t992r1372b1047],
9	revealed	VBD	O	reveal	_	0	SENT_79	[p5l1407t992r1684b1047],
10	a	DT	O	a	det	12	SENT_79	[p5l1717t1006r1755b1047],
11	subcorneal	NN	O	subcorneal	nn	12	SENT_79	[p5l1784t992r2148b1047],
12	pustule	NN	O	pustule	dobj	9	SENT_79	[p5l11t1085r250b1154],
13	in	IN	O	in	_	0	SENT_79	[p5l313t1085r362b1139],
14	the	DT	O	the	det	16	SENT_79	[p5l423t1085r527b1140],
15	follicular	JJ	O	follicular	amod	16	SENT_79	[p5l587t1085r865b1140],
16	opening	NN	O	opening	prep_in	9	SENT_79	[p5l923t1085r1186b1155],
17	with	IN	O	with	_	0	SENT_79	[p5l1249t1085r1382b1139],
18	underlying	VBG	O	underlie	amod	22	SENT_79	[p5l1448t1085r1785b1155],
19	folliculitis	NN	O	folliculitis	nn	22	SENT_79	[p5l1848t1085r2150b1140],
20	(	NN	O	(	nn	22	SENT_79	[p5l10t1177r640b1248],
21	hematoxy	NN	O	hematoxy	nn	22	SENT_79	[p5l10t1177r640b1248],
22	|	NN	O	|	prep_with	16	SENT_79	[p5l10t1177r640b1248],
23	in	IN	O	in	_	0	SENT_79	[p5l10t1177r640b1248],
24	—	NN	O	—	nn	25	SENT_79	[p5l10t1177r640b1248],
25	eosin	NN	O	eosin	prep_in	22	SENT_79	[p5l10t1177r640b1248],
26	[	CD	NUMBER	[	num	25	SENT_79	[p5l694t1177r843b1247],
27	HE	PRP	O	he	tmod	22	SENT_79	[p5l694t1177r843b1247],
28	]	RB	O	]	advmod	27	SENT_79	[p5l694t1177r843b1247],
29	,	,	O	,	_	0	SENT_79	[p5l694t1177r843b1247],
30	original	JJ	O	original	amod	33	SENT_79	[p5l896t1178r1131b1248],
31	magnification	NN	O	magnification	nn	33	SENT_79	[p5l1184t1178r1624b1248],
32	x40	NN	O	x40	nn	33	SENT_79	[p5l1683t1177r1849b1247],
33	)	NN	O	)	appos	16	SENT_79	[p5l1683t1177r1849b1247],
34	.	.	O	.	_	0	SENT_79	[p5l1683t1177r1849b1247],

1	(	NN	O	(	nn	2	SENT_80	[p5l1902t1177r1979b1247],
2	b	NN	O	b	nsubj	11	SENT_80	[p5l1902t1177r1979b1247],
3	)	CD	NUMBER	)	dep	2	SENT_80	[p5l1902t1177r1979b1247],
4	The	DT	O	the	det	6	SENT_80	[p5l2027t1178r2150b1233],
5	inflammatory	JJ	O	inflammatory	amod	6	SENT_80	[p5l11t1271r439b1341],
6	cells	NNS	O	cell	dep	2	SENT_80	[p5l471t1271r618b1326],
7	around	IN	O	around	_	0	SENT_80	[p5l651t1271r880b1326],
8	the	DT	O	the	det	9	SENT_80	[p5l913t1271r1016b1326],
9	follicle	NN	O	follicle	prep_around	6	SENT_80	[p5l1047t1271r1256b1326],
10	were	VBD	O	be	cop	11	SENT_80	[p5l1288t1285r1448b1326],
11	eosinophil	NN	O	eosinophil	_	0	SENT_80	[p5l1480t1271r1814b1340],
12	predominant	JJ	O	predominant	amod	11	SENT_80	[p5l1851t1271r2150b1340, p5l11t1367r152b1419],
13	(	CD	NUMBER	(	tmod	12	SENT_80	[p5l182t1363r312b1433],
14	HE	PRP	O	he	dep	11	SENT_80	[p5l182t1363r312b1433],
15	,	,	O	,	_	0	SENT_80	[p5l182t1363r312b1433],
16	x100	CD	NUMBER	x100	num	17	SENT_80	[p5l353t1363r561b1433],
17	)	NN	O	)	appos	11	SENT_80	[p5l353t1363r561b1433],
18	.	.	O	.	_	0	SENT_80	[p5l353t1363r561b1433],

1	(	NN	O	(	nn	2	SENT_81	[p5l595t1363r667b1433],
2	c	NN	O	c	nsubj	9	SENT_81	[p5l595t1363r667b1433],
3	)	CD	NUMBER	)	num	5	SENT_81	[p5l595t1363r667b1433],
4	Skin	NN	O	skin	nn	5	SENT_81	[p5l698t1363r837b1420],
5	biopsy	NN	O	biopsy	dep	2	SENT_81	[p5l870t1364r1088b1434],
6	of	IN	O	of	_	0	SENT_81	[p5l1116t1364r1179b1419],
7	the	DT	O	the	det	8	SENT_81	[p5l1204t1364r1307b1419],
8	leg	NN	O	leg	prep_of	2	SENT_81	[p5l1338t1364r1429b1434],
9	showed	VBD	O	show	_	0	SENT_81	[p5l1461t1364r1718b1419],
10	perivascular	JJ	O	perivascular	amod	12	SENT_81	[p5l1751t1364r2153b1433],
11	lymphocytic	JJ	O	lymphocytic	amod	12	SENT_81	[p5l11t1458r408b1527],
12	infiltration	NN	O	infiltration	iobj	9	SENT_81	[p5l466t1457r783b1513],
13	(	CD	NUMBER	(	num	12	SENT_81	[p5l841t1456r972b1527],
14	HE	PRP	O	he	dobj	9	SENT_81	[p5l841t1456r972b1527],
15	,	,	O	,	_	0	SENT_81	[p5l841t1456r972b1527],
16	>	JJR	O	>	dobj	9	SENT_81	[p5l1038t1456r1204b1527],
17	<	JJR	O	<	dep	16	SENT_81	[p5l1038t1456r1204b1527],
18	40	CD	NUMBER	40	num	19	SENT_81	[p5l1038t1456r1204b1527],
19	)	NN	O	)	dep	17	SENT_81	[p5l1038t1456r1204b1527],
20	.	.	O	.	_	0	SENT_81	[p5l1038t1456r1204b1527],

1	(	NN	O	(	nn	2	SENT_82	[p5l1264t1456r1341b1527],
2	d	NN	O	d	nsubj	7	SENT_82	[p5l1264t1456r1341b1527],
3	)	CD	NUMBER	)	dep	2	SENT_82	[p5l1264t1456r1341b1527],
4	The	DT	O	the	det	6	SENT_82	[p5l1395t1458r1518b1513],
5	high-power	JJ	O	high-power	amod	6	SENT_82	[p5l1575t1458r1951b1527],
6	view	NN	O	view	dep	2	SENT_82	[p5l2002t1458r2151b1513],
7	showed	VBD	O	show	_	0	SENT_82	[p5l8t1550r266b1605],
8	fibrinoid	JJ	O	fibrinoid	amod	9	SENT_82	[p5l310t1550r575b1605],
9	necrosis	NN	O	necrosis	dobj	7	SENT_82	[p5l623t1550r899b1605],
10	of	IN	O	of	_	0	SENT_82	[p5l942t1550r1006b1605],
11	vascular	JJ	O	vascular	amod	12	SENT_82	[p5l1045t1550r1324b1605],
12	walls	NNS	O	wall	prep_of	9	SENT_82	[p5l1364t1550r1529b1605],
13	with	IN	O	with	_	0	SENT_82	[p5l1572t1550r1704b1604],
14	lymphocytic	JJ	O	lymphocytic	amod	15	SENT_82	[p5l1753t1550r2150b1620],
15	infiltration	NN	O	infiltration	prep_with	12	SENT_82	[p5l11t1643r329b1699],
16	and	CC	O	and	_	0	SENT_82	[p5l359t1643r479b1699],
17	red	JJ	O	red	amod	20	SENT_82	[p5l512t1643r613b1699],
18	blood	NN	O	blood	nn	20	SENT_82	[p5l647t1643r829b1699],
19	cell	NN	O	cell	nn	20	SENT_82	[p5l861t1643r967b1699],
20	extravasation	NN	O	extravasation	conj_and	12	SENT_82	[p5l999t1643r1440b1699],
21	(	CD	NUMBER	(	dep	20	SENT_82	[p5l1472t1642r1604b1712],
22	HE	PRP	O	he	tmod	7	SENT_82	[p5l1472t1642r1604b1712],
23	,	,	O	,	_	0	SENT_82	[p5l1472t1642r1604b1712],
24	x400	NN	O	x400	nn	25	SENT_82	[p5l1644t1642r1852b1712],
25	)	NN	O	)	appos	22	SENT_82	[p5l1644t1642r1852b1712],
26	.	.	O	.	_	0	SENT_82	[p5l1644t1642r1852b1712],

1	The	DT	O	the	det	3	SENT_83	[p5l100t1822r224b1878],
2	initial	JJ	O	initial	amod	3	SENT_83	[p5l276t1822r437b1878],
3	presentation	NN	O	presentation	nsubj	8	SENT_83	[p5l492t1823r901b1892],
4	of	IN	O	of	_	0	SENT_83	[p5l952t1822r1016b1878],
5	this	DT	O	this	det	6	SENT_83	[p5l1061t1822r1177b1878],
6	patient	NN	O	patient	prep_of	3	SENT_83	[p5l1230t1823r1454b1892],
7	was	VBD	O	be	cop	8	SENT_83	[p5l1502t1836r1634b1878],
8	suggestive	JJ	O	suggestive	_	0	SENT_83	[p5l1684t1823r2039b1892],
9	of	IN	O	of	_	0	SENT_83	[p5l2090t1822r2153b1878],
10	acute	JJ	O	acute	prep_of	8	SENT_83	[p5l9t1927r191b1979],
11	generalized	VBN	O	generalize	partmod	10	SENT_83	[p5l229t1924r606b1993],
12	exanthematous	JJ	O	exanthematous	amod	13	SENT_83	[p5l648t1924r1159b1979],
13	pustulosis	NN	O	pustulosis	dobj	11	SENT_83	[p5l1199t1924r1530b1993],
14	(	CD	NUMBER	(	num	16	SENT_83	[p5l1570t1923r1802b1993],
15	AGEP	NN	O	agep	nn	16	SENT_83	[p5l1570t1923r1802b1993],
16	)	NN	O	)	dep	13	SENT_83	[p5l1570t1923r1802b1993],
17	and	CC	O	and	_	0	SENT_83	[p5l1841t1924r1981b1989],
18	,	,	O	,	_	0	SENT_83	[p5l1841t1924r1981b1989],
19	less	JJR	O	less	dep	20	SENT_83	[p5l2025t1924r2150b1979],
20	consistent	JJ	O	consistent	dep	13	SENT_83	[p5l9t2026r350b2082],
21	with	IN	O	with	_	0	SENT_83	[p5l376t2026r509b2080],
22	the	DT	O	the	det	24	SENT_83	[p5l537t2026r640b2082],
23	final	JJ	O	final	amod	24	SENT_83	[p5l667t2026r799b2081],
24	diagnosis	NN	O	diagnosis	prep_with	20	SENT_83	[p5l829t2026r1161b2096],
25	,	,	O	,	_	0	SENT_83	[p5l829t2026r1161b2096],
26	DRESS	NN	O	dress	dobj	11	SENT_83	[p5l1196t2025r1453b2082],
27	.	.	O	.	_	0	SENT_83	[p5l1196t2025r1453b2082],

1	We	PRP	O	we	nsubj	2	SENT_84	[p5l1484t2026r1591b2081],
2	scored	VBD	O	score	_	0	SENT_84	[p5l1619t2026r1843b2081],
3	both	CC	O	both	prep	2	SENT_84	[p5l1876t2026r2019b2081],
4	the	DT	O	the	det	6	SENT_84	[p5l2048t2026r2151b2081],
5	European	JJ	O	european	amod	6	SENT_84	[p5l12t2129r324b2198],
6	Registry	NN	O	registry	dep	3	SENT_84	[p5l387t2129r656b2198],
7	of	IN	O	of	_	0	SENT_84	[p5l711t2128r774b2184],
8	Severe	JJ	O	severe	amod	13	SENT_84	[p5l830t2127r1058b2184],
9	Cutaneous	JJ	O	cutaneous	amod	13	SENT_84	[p5l1116t2127r1473b2184],
10	Adverse	JJ	O	adverse	amod	13	SENT_84	[p5l1528t2129r1800b2184],
11	Reaction	NN	O	reaction	nn	13	SENT_84	[p5l1861t2129r2148b2184],
12	(	NN	O	(	nn	13	SENT_84	[p5l10t2228r395b2299],
13	RegiSCAR	NN	O	regiscar	prep_of	6	SENT_84	[p5l10t2228r395b2299],
14	)	CD	NUMBER	)	num	15	SENT_84	[p5l10t2228r395b2299],
15	criteria	NNS	O	criterion	dobj	2	SENT_84	[p5l423t2214r668b2285],
16	‘	CD	NUMBER	‘	nsubj	25	SENT_84	[p5l423t2214r668b2285],
17	for	IN	O	for	_	0	SENT_84	[p5l702t2229r792b2285],
18	DRESS	NN	O	dress	prep_for	16	SENT_84	[p5l819t2228r1059b2285],
19	and	CC	O	and	_	0	SENT_84	[p5l1086t2230r1205b2285],
20	EuroSCAR	NN	O	euroscar	nn	23	SENT_84	[p5l1238t2228r1586b2285],
21	AGEP	NN	O	agep	nn	23	SENT_84	[p5l1610t2228r1808b2285],
22	validation	NN	O	validation	nn	23	SENT_84	[p5l1834t2230r2148b2285],
23	score2	NN	O	score2	prep_for	16	SENT_84	[p5l9t2317r220b2387],
24	to	TO	O	to	aux	25	SENT_84	[p5l270t2335r333b2387],
25	see	VB	O	see	infmod	15	SENT_84	[p5l384t2346r498b2387],
26	if	IN	O	if	mark	35	SENT_84	[p5l550t2332r585b2386],
27	this	DT	O	this	det	28	SENT_84	[p5l630t2332r746b2387],
28	patient	NN	O	patient	nsubj	35	SENT_84	[p5l799t2332r1023b2401],
29	presented	VBN	O	present	partmod	28	SENT_84	[p5l1074t2332r1403b2401],
30	with	IN	O	with	_	0	SENT_84	[p5l1453t2332r1586b2386],
31	a	DT	O	a	det	32	SENT_84	[p5l1638t2346r1676b2387],
32	diagnosis	NN	O	diagnosis	prep_with	29	SENT_84	[p5l1725t2332r2039b2402],
33	of	IN	O	of	_	0	SENT_84	[p5l2090t2332r2153b2387],
34	DRESS/AGEP	NN	O	dress/agep	prep_of	32	SENT_84	[p5l12t2433r475b2490],
35	overlap	VBP	O	overlap	advcl	25	SENT_84	[p5l510t2435r753b2504],
36	or	CC	O	or	_	0	SENT_84	[p5l786t2449r852b2490],
37	definite	JJ	O	definite	amod	38	SENT_84	[p5l885t2434r1126b2490],
38	DRESS	NN	O	dress	dobj	2	SENT_84	[p5l1163t2433r1420b2490],
39	.	.	O	.	_	0	SENT_84	[p5l1163t2433r1420b2490],

1	The	DT	O	the	det	2	SENT_85	[p5l1455t2435r1579b2490],
2	score	NN	NUMBER	score	nsubj	4	SENT_85	[p5l1612t2449r1794b2490],
3	was	VBD	O	be	cop	4	SENT_85	[p5l1827t2449r1959b2490],
4	6	CD	NUMBER	6	_	0	SENT_85	[p5l1994t2435r2030b2490],
5	for	IN	O	for	_	0	SENT_85	[p5l2063t2434r2153b2490],
6	DRESS	NN	O	dress	prep_for	4	SENT_85	[p5l12t2535r269b2601],
7	,	,	O	,	_	0	SENT_85	[p5l12t2535r269b2601],
8	a	DT	O	a	det	10	SENT_85	[p5l303t2550r340b2591],
9	definite	JJ	O	definite	amod	10	SENT_85	[p5l370t2535r612b2591],
10	case	NN	O	case	prep_for	4	SENT_85	[p5l642t2550r814b2601],
11	,	,	O	,	_	0	SENT_85	[p5l642t2550r814b2601],
12	and	CC	O	and	_	0	SENT_85	[p5l848t2536r968b2591],
13	2	CD	NUMBER	2	prep_for	4	SENT_85	[p5l1000t2536r1036b2590],
14	for	IN	O	for	_	0	SENT_85	[p5l1066t2535r1156b2591],
15	AGEP	NN	ORGANIZATION	agep	prep_for	13	SENT_85	[p5l1182t2535r1397b2601],
16	,	,	O	,	_	0	SENT_85	[p5l1182t2535r1397b2601],
17	a	DT	O	a	det	19	SENT_85	[p5l1432t2550r1469b2591],
18	probable	JJ	O	probable	amod	19	SENT_85	[p5l1501t2536r1793b2605],
19	case	NN	O	case	appos	15	SENT_85	[p5l1823t2550r1995b2591],
20	.	.	O	.	_	0	SENT_85	[p5l1823t2550r1995b2591],

1	The	DT	O	the	det	3	SENT_86	[p5l2027t2536r2150b2591],
2	clinical	JJ	O	clinical	amod	3	SENT_86	[p5l9t2637r231b2692],
3	features	NNS	O	feature	_	0	SENT_86	[p5l258t2637r527b2692],
4	which	WDT	O	which	nsubj	6	SENT_86	[p5l553t2637r744b2692],
5	most	RBS	O	most	advmod	6	SENT_86	[p5l775t2640r937b2692],
6	differentiated	VBN	O	differentiate	dep	3	SENT_86	[p5l964t2637r1397b2692],
7	DRESS	NN	O	dress	dobj	6	SENT_86	[p5l1431t2636r1670b2692],
8	from	IN	O	from	_	0	SENT_86	[p5l1696t2637r1844b2692],
9	AGEP	NN	O	agep	prep_from	6	SENT_86	[p5l1871t2636r2069b2692],
10	in	IN	O	in	prep	6	SENT_86	[p5l2099t2637r2148b2691],

1	1078	CD	DATE	1078	nsubj	10	SENT_87	[p5l13t2861r190b2922],
2	our	PRP$	O	we	poss	3	SENT_87	[p5l8t2983r115b3024],
3	patient	NN	O	patient	dep	1	SENT_87	[p5l165t2969r389b3038],
4	were	VBD	O	be	cop	10	SENT_87	[p5l437t2983r597b3024],
5	the	DT	O	the	det	10	SENT_87	[p5l644t2969r747b3024],
6	delayed	VBN	O	delay	amod	10	SENT_87	[p5l797t2969r1054b3039],
7	onset	NN	O	onset	nn	10	SENT_87	[p5l1107t2972r1305b3034],
8	,	,	O	,	_	0	SENT_87	[p5l1107t2972r1305b3034],
9	protracted	JJ	O	protracted	amod	10	SENT_87	[p5l1361t2969r1701b3038],
10	course	NN	O	course	_	0	SENT_87	[p5l1754t2983r1977b3024],
11	and	CC	O	and	_	0	SENT_87	[p5l2027t2969r2146b3024],
12	multi-organ	JJ	O	multi-organ	amod	13	SENT_87	[p5l10t3071r384b3141],
13	involvement	NN	O	involvement	conj_and	10	SENT_87	[p5l415t3071r826b3126],
14	.	.	O	.	_	0	SENT_87	[p5l415t3071r826b3126],

1	Drug	NN	O	drug	nn	2	SENT_88	[p5l105t3174r257b3243],
2	rash	NN	O	rash	nsubj	9	SENT_88	[p5l295t3174r431b3229],
3	with	IN	O	with	_	0	SENT_88	[p5l465t3174r598b3228],
4	eosinophilia	NN	O	eosinophilia	nn	7	SENT_88	[p5l635t3174r1027b3243],
5	and	CC	O	and	_	0	SENT_88	[p5l1061t3174r1180b3229],
6	systemic	JJ	O	systemic	conj_and	4	SENT_88	[p5l1216t3174r1509b3243],
7	symptoms	NNS	O	symptom	prep_with	2	SENT_88	[p5l1543t3176r1889b3243],
8	usually	RB	O	usually	advmod	9	SENT_88	[p5l1925t3174r2151b3243],
9	manifests	VBZ	O	manifest	_	0	SENT_88	[p5l10t3275r327b3330],
10	as	IN	O	as	quantmod	11	SENT_88	[p5l360t3289r435b3330],
11	a	DT	O	a	dobj	9	SENT_88	[p5l469t3289r506b3330],
12	generalized	VBN	O	generalize	partmod	11	SENT_88	[p5l541t3275r917b3345],
13	maculopapular	JJ	O	maculopapular	amod	14	SENT_88	[p5l957t3275r1450b3344],
14	eruption	NN	O	eruption	dobj	12	SENT_88	[p5l1483t3275r1771b3344],
15	.	.	O	.	_	0	SENT_88	[p5l1483t3275r1771b3344],

1	Pathological	JJ	O	pathological	amod	2	SENT_89	[p5l1813t3275r2149b3345, p5l8t3377r99b3432],
2	changes	NNS	O	change	nsubj	3	SENT_89	[p5l136t3377r416b3447],
3	include	VBP	O	include	dep	22	SENT_89	[p5l453t3377r688b3432],
4	lichenoid	JJ	O	lichenoid	amod	5	SENT_89	[p5l724t3377r1015b3432],
5	dermatitis	NN	O	dermatitis	dobj	3	SENT_89	[p5l1052t3377r1395b3442],
6	,	,	O	,	_	0	SENT_89	[p5l1052t3377r1395b3442],
7	erythema	NN	O	erythema	nn	8	SENT_89	[p5l1434t3377r1743b3447],
8	multiforme	NN	O	multiforme	dobj	3	SENT_89	[p5l1779t3377r2144b3442],
9	,	,	O	,	_	0	SENT_89	[p5l1779t3377r2144b3442],
10	pseudolymphoma	NN	O	pseudolymphoma	dobj	3	SENT_89	[p5l10t3479r606b3549],
11	and	CC	O	and	_	0	SENT_89	[p5l640t3479r759b3534],
12	vascu	NN	O	vascu	nn	15	SENT_89	[p5l795t3464r1150b3534],
13	|	CD	NUMBER	|	num	15	SENT_89	[p5l795t3464r1150b3534],
14	itis	NN	O	iti	nn	15	SENT_89	[p5l795t3464r1150b3534],
15	.3	NN	NUMBER	.3	dobj	3	SENT_89	[p5l795t3464r1150b3534],
16	There	EX	O	there	expl	22	SENT_89	[p5l1183t3479r1372b3534],
17	have	VBP	O	have	aux	22	SENT_89	[p5l1408t3479r1562b3534],
18	been	VBN	O	be	cop	22	SENT_89	[p5l1599t3479r1757b3534],
19	only	RB	O	only	quantmod	21	SENT_89	[p5l1794t3479r1930b3549],
20	a	DT	O	a	quantmod	21	SENT_89	[p5l1963t3493r2000b3534],
21	few	JJ	O	few	num	22	SENT_89	[p5l2032t3479r2150b3534],
22	cases	NNS	O	case	_	0	SENT_89	[p6l8t37r200b78],
23	of	IN	O	of	_	0	SENT_89	[p6l238t22r301b78],
24	anticonvulsant-induced	JJ	O	anticonvulsant-induced	amod	25	SENT_89	[p6l336t23r1111b78],
25	DRESS	NN	O	dress	prep_of	22	SENT_89	[p6l1154t22r1394b78],
26	manifesting	VBG	O	manifest	partmod	25	SENT_89	[p6l1433t22r1811b92],
27	as	IN	O	as	mark	51	SENT_89	[p6l1851t37r1925b78],
28	atypical	JJ	O	atypical	nsubj	51	SENT_89	[p6l1962t23r2148b92, p6l8t125r99b180],
29	generalized	VBN	O	generalize	partmod	28	SENT_89	[p6l135t125r513b195],
30	pustulosis	NN	O	pustulosis	nsubj	31	SENT_89	[p6l552t125r883b194],
31	reported	VBD	O	report	ccomp	29	SENT_89	[p6l919t125r1196b194],
32	previously	RB	DATE	previously	advmod	33	SENT_89	[p6l1235t110r1619b195],
33	.4	CD	NUMBER	.4	dobj	31	SENT_89	[p6l1235t110r1619b195],
34	These	DT	O	these	det	35	SENT_89	[p6l1651t125r1852b180],
35	patients	NNS	O	patient	nsubj	36	SENT_89	[p6l1889t125r2149b195],
36	had	VBD	O	have	rcmod	33	SENT_89	[p6l10t206r127b261],
37	some	DT	O	some	det	40	SENT_89	[p6l163t220r344b261],
38	common	JJ	O	common	amod	40	SENT_89	[p6l377t220r666b261],
39	cutaneous	JJ	O	cutaneous	amod	40	SENT_89	[p6l701t209r1045b261],
40	features	NNS	O	feature	dobj	36	SENT_89	[p6l1076t205r1361b261],
41	:	:	O	:	_	0	SENT_89	[p6l1076t205r1361b261],
42	an	DT	O	a	det	45	SENT_89	[p6l1398t220r1474b261],
43	erythematous	JJ	O	erythematous	amod	45	SENT_89	[p6l1510t206r1962b275],
44	papular	JJ	O	papular	amod	45	SENT_89	[p6l1997t220r2148b275, p6l10t307r129b362],
45	eruption	NN	O	eruption	dep	40	SENT_89	[p6l171t307r439b376],
46	that	WDT	O	that	nsubj	47	SENT_89	[p6l483t307r610b362],
47	evolved	VBD	O	evolve	rcmod	45	SENT_89	[p6l653t307r906b362],
48	to	TO	O	to	_	0	SENT_89	[p6l950t310r1014b362],
49	follicular	JJ	O	follicular	amod	50	SENT_89	[p6l1056t306r1334b362],
50	pustules	NNS	O	pustule	prep_to	47	SENT_89	[p6l1378t307r1653b376],
51	noted	VBD	O	note	advcl	26	SENT_89	[p6l1699t307r1882b362],
52	initially	RB	O	initially	advmod	51	SENT_89	[p6l1931t307r2151b376],
53	over	IN	O	over	_	0	SENT_89	[p6l8t423r152b465],
54	the	DT	O	the	det	55	SENT_89	[p6l176t410r279b465],
55	scalp	NN	O	scalp	prep_over	51	SENT_89	[p6l307t410r482b479],
56	and	CC	O	and	_	0	SENT_89	[p6l510t410r630b465],
57	face	NN	O	face	conj_and	55	SENT_89	[p6l659t409r800b465],
58	with	IN	O	with	_	0	SENT_89	[p6l827t410r960b464],
59	subsequent	JJ	O	subsequent	amod	60	SENT_89	[p6l991t410r1378b479],
60	generalization	NN	O	generalization	prep_with	55	SENT_89	[p6l1406t410r1882b479],
61	.	.	O	.	_	0	SENT_89	[p6l1406t410r1882b479],

1	In	IN	O	in	_	0	SENT_90	[p6l1918t410r1969b464],
2	contrast	NN	O	contrast	prep_in	21	SENT_90	[p6l2000t423r2148b465, p6l6t514r170b576],
3	,	,	O	,	_	0	SENT_90	[p6l2000t423r2148b465, p6l6t514r170b576],
4	AGEP	NN	O	agep	nsubj	21	SENT_90	[p6l204t510r402b566],
5	usually	RB	O	usually	advmod	6	SENT_90	[p6l437t511r663b580],
6	manifested	VBN	O	manifest	partmod	4	SENT_90	[p6l697t510r1058b566],
7	as	IN	O	as	_	0	SENT_90	[p6l1093t525r1167b566],
8	pinhead-sized	JJ	O	pinhead-sized	amod	11	SENT_90	[p6l1203t511r1684b580],
9	,	,	O	,	_	0	SENT_90	[p6l1203t511r1684b580],
10	non-follicular	JJ	O	non-follicular	amod	11	SENT_90	[p6l1724t510r2151b566],
11	pustules	NNS	O	pustule	prep_as	6	SENT_90	[p6l10t613r286b682],
12	on	IN	O	on	_	0	SENT_90	[p6l326t626r404b668],
13	edematous	JJ	O	edematous	amod	15	SENT_90	[p6l447t613r817b668],
14	erythematous	JJ	O	erythematous	amod	15	SENT_90	[p6l858t613r1310b682],
15	bases	NNS	O	basis	prep_on	6	SENT_90	[p6l1353t613r1547b668],
16	arising	VBG	O	arise	partmod	15	SENT_90	[p6l1588t613r1801b682],
17	mainly	RB	O	mainly	advmod	16	SENT_90	[p6l1846t613r2056b682],
18	in	IN	O	in	_	0	SENT_90	[p6l2098t613r2147b667],
19	the	DT	O	the	det	20	SENT_90	[p6l6t716r109b771],
20	skin	NN	O	skin	prep_in	16	SENT_90	[p6l138t716r266b771],
21	folds	VBZ	O	fold	_	0	SENT_90	[p6l295t715r472b771],
22	.	.	O	.	_	0	SENT_90	[p6l295t715r472b771],

1	Vasculitis	NNP	O	Vasculitis	nsubj	4	SENT_91	[p6l502t716r816b771],
2	is	VBZ	O	be	cop	4	SENT_91	[p6l848t716r895b771],
3	generally	RB	O	generally	advmod	4	SENT_91	[p6l924t716r1222b785],
4	absent	JJ	O	absent	_	0	SENT_91	[p6l1250t716r1474b771],
5	in	IN	O	in	_	0	SENT_91	[p6l1504t716r1553b770],
6	AGEP	NN	O	agep	prep_in	4	SENT_91	[p6l1582t714r1797b771],
7	.	.	O	.	_	0	SENT_91	[p6l1582t714r1797b771],

1	The	DT	O	the	det	2	SENT_92	[p6l99t817r223b872],
2	mechanism	NN	O	mechanism	nsubj	10	SENT_92	[p6l269t817r646b872],
3	of	IN	O	of	_	0	SENT_92	[p6l693t816r756b872],
4	pustule	NN	O	pustule	nn	5	SENT_92	[p6l800t817r1038b886],
5	formation	NN	O	formation	prep_of	2	SENT_92	[p6l1081t816r1395b872],
6	in	IN	O	in	_	0	SENT_92	[p6l1443t817r1492b871],
7	DRESS	NNP	O	DRESS	prep_in	5	SENT_92	[p6l1542t816r1782b872],
8	has	VBZ	O	have	aux	10	SENT_92	[p6l1829t817r1942b872],
9	been	VBN	O	be	cop	10	SENT_92	[p6l1989t817r2147b872],
10	unknown	JJ	O	unknown	_	0	SENT_92	[p6l10t919r324b974],
11	.	.	O	.	_	0	SENT_92	[p6l10t919r324b974],

1	From	IN	O	from	_	0	SENT_93	[p6l364t919r529b974],
2	the	DT	O	the	det	4	SENT_93	[p6l562t919r665b974],
3	histological	JJ	O	histological	amod	4	SENT_93	[p6l700t919r1068b989],
4	examination	NN	O	examination	prep_from	10	SENT_93	[p6l1103t919r1501b974],
5	of	IN	O	of	_	0	SENT_93	[p6l1537t918r1599b974],
6	this	DT	O	this	det	7	SENT_93	[p6l1628t919r1744b974],
7	patient	NN	O	patient	prep_of	4	SENT_93	[p6l1779t919r2019b988],
8	,	,	O	,	_	0	SENT_93	[p6l1779t919r2019b988],
9	we	PRP	O	we	nsubj	10	SENT_93	[p6l2055t933r2149b974],
10	found	VBD	O	find	_	0	SENT_93	[p6l6t1020r192b1076],
11	that	IN	O	that	complm	13	SENT_93	[p6l231t1021r358b1076],
12	folliculitis	NN	O	folliculitis	nsubj	13	SENT_93	[p6l394t1020r697b1076],
13	infiltrated	VBN	O	infiltrate	ccomp	10	SENT_93	[p6l738t1020r1039b1076],
14	by	IN	O	by	_	0	SENT_93	[p6l1081t1021r1158b1090],
15	lymphocytes	NNS	O	lymphocyte	prep_by	13	SENT_93	[p6l1198t1021r1616b1090],
16	and	CC	O	and	_	0	SENT_93	[p6l1654t1021r1774b1076],
17	prominent	JJ	O	prominent	amod	18	SENT_93	[p6l1817t1021r2149b1090],
18	eosinophils	NNS	O	eosinophil	prep_by	13	SENT_93	[p6l8t1123r381b1192],
19	and	CC	O	and	_	0	SENT_93	[p6l432t1123r551b1178],
20	a	DT	O	a	det	21	SENT_93	[p6l606t1137r643b1178],
21	pustule	NN	O	pustule	prep_by	13	SENT_93	[p6l696t1123r935b1192],
22	within	IN	O	within	_	0	SENT_93	[p6l984t1123r1175b1177],
23	the	DT	O	the	det	25	SENT_93	[p6l1226t1123r1330b1178],
24	follicular	JJ	O	follicular	amod	25	SENT_93	[p6l1379t1122r1656b1178],
25	opening	NN	O	opening	prep_within	21	SENT_93	[p6l1705t1123r1988b1192],
26	.	.	O	.	_	0	SENT_93	[p6l1705t1123r1988b1192],

1	We	PRP	O	we	nsubj	2	SENT_94	[p6l2042t1123r2150b1178],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_94	[p6l10t1225r446b1294],
3	that	IN	O	that	complm	7	SENT_94	[p6l484t1225r611b1280],
4	the	DT	O	the	det	6	SENT_94	[p6l646t1225r749b1280],
5	drug	NN	O	drug	nn	6	SENT_94	[p6l786t1225r933b1295],
6	reaction	NN	O	reaction	nsubj	7	SENT_94	[p6l974t1225r1237b1280],
7	led	VBD	O	lead	ccomp	2	SENT_94	[p6l1278t1225r1370b1280],
8	to	TO	O	to	dep	12	SENT_94	[p6l1408t1228r1472b1280],
9	folliculitis	NN	O	folliculitis	pobj	8	SENT_94	[p6l1507t1224r1810b1280],
10	and	CC	O	and	_	0	SENT_94	[p6l1847t1225r1967b1280],
11	then	RB	O	then	conj_and	8	SENT_94	[p6l2005t1225r2146b1280],
12	pustules	NNS	O	pustule	dobj	7	SENT_94	[p6l10t1327r303b1396],
13	.	.	O	.	_	0	SENT_94	[p6l10t1327r303b1396],

1	Allopurinol-induced	JJ	O	allopurinol-induced	nsubjpass	14	SENT_95	[p6l99t1429r743b1498],
2	generalized	VBN	O	generalize	partmod	1	SENT_95	[p6l812t1429r1190b1498],
3	“	NN	O	“	dobj	2	SENT_95	[p6l1260t1428r1746b1484],
4	non-fo	JJ	O	non-fo	amod	11	SENT_95	[p6l1260t1428r1746b1484],
5	|	NN	O	|	nn	11	SENT_95	[p6l1260t1428r1746b1484],
6	|	NN	O	|	nn	11	SENT_95	[p6l1260t1428r1746b1484],
7	icu	NN	O	icu	nn	11	SENT_95	[p6l1260t1428r1746b1484],
8	|	CD	NUMBER	|	num	11	SENT_95	[p6l1260t1428r1746b1484],
9	ar	NN	O	ar	nn	11	SENT_95	[p6l1260t1428r1746b1484],
10	”	NN	O	”	nn	11	SENT_95	[p6l1260t1428r1746b1484],
11	pustulosis	NN	O	pustulosis	dep	3	SENT_95	[p6l1818t1429r2150b1498],
12	had	VBD	O	have	aux	14	SENT_95	[p6l10t1530r127b1585],
13	been	VBN	O	be	auxpass	14	SENT_95	[p6l176t1530r334b1585],
14	reported	VBN	O	report	_	0	SENT_95	[p6l381t1530r658b1599],
15	once	RB	DATE	once	advmod	14	SENT_95	[p6l705t1544r866b1585],
16	previous	JJ	O	previous	amod	18	SENT_95	[p6l912t1516r1296b1599],
17	|	JJ	O	|	amod	18	SENT_95	[p6l912t1516r1296b1599],
18	y.	NN	O	y.	dobj	14	SENT_95	[p6l912t1516r1296b1599],
19	5	CD	NUMBER	5	num	18	SENT_95	[p6l912t1516r1296b1599],
20	Unlike	IN	O	unlike	_	0	SENT_95	[p6l1342t1530r1543b1586],
21	our	PRP$	O	we	poss	22	SENT_95	[p6l1586t1544r1693b1585],
22	patient	NN	O	patient	prep_unlike	18	SENT_95	[p6l1737t1530r1976b1599],
23	,	,	O	,	_	0	SENT_95	[p6l1737t1530r1976b1599],
24	that	WDT	O	that	dobj	28	SENT_95	[p6l2023t1530r2150b1585],
25	patient	NN	O	patient	nsubj	28	SENT_95	[p6l10t1632r234b1701],
26	had	VBD	O	have	aux	28	SENT_95	[p6l273t1632r390b1687],
27	an	DT	O	a	dep	28	SENT_95	[p6l430t1646r506b1687],
28	overlap	VBP	O	overlap	dep	14	SENT_95	[p6l545t1632r788b1701],
29	between	IN	O	between	_	0	SENT_95	[p6l828t1632r1107b1687],
30	AGEP	NN	O	agep	prep_between	28	SENT_95	[p6l1144t1631r1342b1688],
31	and	CC	O	and	_	0	SENT_95	[p6l1379t1632r1499b1687],
32	DRESS	NN	O	dress	prep_between	28	SENT_95	[p6l1542t1631r1782b1688],
33	according	VBG	O	accord	_	0	SENT_95	[p6l1819t1632r2147b1702],
34	to	TO	O	to	prepc_according_to	28	SENT_95	[p6l6t1737r69b1789],
35	the	DT	O	the	det	37	SENT_95	[p6l106t1734r210b1789],
36	diagnostic	JJ	O	diagnostic	amod	37	SENT_95	[p6l248t1734r589b1803],
37	criteria	NNS	O	criterion	pobj	28	SENT_95	[p6l628t1734r852b1789],
38	and	CC	O	and	_	0	SENT_95	[p6l890t1734r1009b1789],
39	had	VBD	O	have	conj_and	14	SENT_95	[p6l1053t1734r1170b1789],
40	a	DT	O	a	det	42	SENT_95	[p6l1211t1747r1248b1789],
41	rapid	JJ	O	rapid	amod	42	SENT_95	[p6l1288t1734r1450b1803],
42	recovery	NN	O	recovery	dobj	39	SENT_95	[p6l1493t1747r1793b1803],
43	.	.	O	.	_	0	SENT_95	[p6l1493t1747r1793b1803],

1	However	RB	O	however	advmod	12	SENT_96	[p6l1839t1734r2145b1799],
2	,	,	O	,	_	0	SENT_96	[p6l1839t1734r2145b1799],
3	generalized	VBN	O	generalize	csubjpass	12	SENT_96	[p6l8t1836r385b1906],
4	“	NN	O	“	nsubj	7	SENT_96	[p6l423t1835r755b1891],
5	follicular	JJ	O	follicular	amod	7	SENT_96	[p6l423t1835r755b1891],
6	”	NN	O	”	nn	7	SENT_96	[p6l423t1835r755b1891],
7	pustulosis	NN	O	pustulosis	xcomp	3	SENT_96	[p6l794t1836r1125b1905],
8	in	IN	O	in	_	0	SENT_96	[p6l1161t1836r1210b1890],
9	DRESS	NNP	O	DRESS	prep_in	7	SENT_96	[p6l1249t1835r1489b1891],
10	has	VBZ	O	have	aux	12	SENT_96	[p6l1525t1836r1638b1891],
11	been	VBN	O	be	auxpass	12	SENT_96	[p6l1673t1836r1832b1891],
12	reported	VBN	O	report	_	0	SENT_96	[p6l1869t1836r2146b1905],
13	before	IN	O	before	prep	12	SENT_96	[p6l10t1938r219b1993],
14	only	RB	O	only	pcomp	13	SENT_96	[p6l253t1938r387b2008],
15	in	IN	O	in	_	0	SENT_96	[p6l423t1938r471b1992],
16	the	DT	O	the	det	17	SENT_96	[p6l507t1938r610b1993],
17	use	NN	O	use	prep_in	12	SENT_96	[p6l645t1952r759b1993],
18	of	IN	O	of	_	0	SENT_96	[p6l792t1938r856b1993],
19	an	DT	O	a	det	20	SENT_96	[p6l887t1952r963b1993],
20	anticonvulsant	JJ	O	anticonvulsant	prep_of	17	SENT_96	[p6l999t1938r1479b1993],
21	but	CC	O	but	_	0	SENT_96	[p6l1515t1938r1617b1993],
22	not	RB	O	not	_	0	SENT_96	[p6l1654t1941r1755b1993],
23	allopurinol	NN	O	allopurinol	conj_negcc	20	SENT_96	[p6l1789t1938r2144b2007],
24	.	.	O	.	_	0	SENT_96	[p6l1789t1938r2144b2007],

1	We	PRP	O	we	nsubj	3	SENT_97	[p6l6t2040r113b2095],
2	herein	RB	O	herein	advmod	3	SENT_97	[p6l165t2040r362b2095],
3	report	VBP	O	report	_	0	SENT_97	[p6l416t2043r612b2109],
4	the	DT	O	the	det	7	SENT_97	[p6l659t2040r762b2095],
5	first	JJ	ORDINAL	first	amod	7	SENT_97	[p6l811t2039r934b2095],
6	allopurinol-induced	JJ	O	allopurinol-induced	amod	7	SENT_97	[p6l983t2040r1617b2109],
7	DRESS	NN	O	dress	dobj	3	SENT_97	[p6l1673t2039r1912b2095],
8	manifested	VBN	O	manifest	partmod	7	SENT_97	[p6l1964t2040r2148b2095, p6l6t2141r209b2197],
9	as	IN	O	as	mark	10	SENT_97	[p6l266t2156r340b2197],
10	generalized	VBN	O	generalize	advcl	8	SENT_97	[p6l394t2142r771b2212],
11	follicular	JJ	O	follicular	amod	12	SENT_97	[p6l826t2141r1103b2197],
12	pustulosis	NN	O	pustulosis	dobj	10	SENT_97	[p6l1157t2142r1488b2211],
13	mimicking	VBG	O	mimic	partmod	12	SENT_97	[p6l1545t2142r1876b2212],
14	AGEP	NN	O	agep	dobj	13	SENT_97	[p6l1930t2141r2145b2197],
15	.	.	O	.	_	0	SENT_97	[p6l1930t2141r2145b2197],

1	Recognition	NN	O	recognition	nsubj	14	SENT_98	[p6l11t2244r401b2314],
2	of	IN	O	of	_	0	SENT_98	[p6l437t2244r500b2299],
3	generalized	VBN	O	generalize	prepc_of	1	SENT_98	[p6l532t2244r909b2314],
4	“	NN	O	“	nsubj	7	SENT_98	[p6l948t2244r1280b2299],
5	follicular	JJ	O	follicular	amod	7	SENT_98	[p6l948t2244r1280b2299],
6	”	NN	O	”	nn	7	SENT_98	[p6l948t2244r1280b2299],
7	pustulosis	NN	O	pustulosis	xcomp	3	SENT_98	[p6l1319t2244r1651b2313],
8	as	IN	O	as	_	0	SENT_98	[p6l1684t2258r1758b2299],
9	a	DT	O	a	det	10	SENT_98	[p6l1792t2258r1829b2299],
10	manifestation	NN	O	manifestation	prep_as	7	SENT_98	[p6l1865t2244r2148b2299, p6l6t2346r189b2402],
11	of	IN	O	of	_	0	SENT_98	[p6l235t2346r298b2402],
12	DRESS	NN	O	dress	prep_of	10	SENT_98	[p6l342t2345r582b2402],
13	is	VBZ	O	be	cop	14	SENT_98	[p6l627t2346r674b2402],
14	important	JJ	O	important	_	0	SENT_98	[p6l720t2346r1052b2415],
15	,	,	O	,	_	0	SENT_98	[p6l720t2346r1052b2415],
16	because	IN	O	because	mark	21	SENT_98	[p6l1101t2346r1380b2402],
17	patients	NNS	O	patient	nsubj	21	SENT_98	[p6l1425t2346r1686b2415],
18	with	IN	O	with	_	0	SENT_98	[p6l1729t2346r1861b2401],
19	DRESS	NN	O	dress	prep_with	17	SENT_98	[p6l1909t2345r2149b2402],
20	often	RB	O	often	advmod	21	SENT_98	[p6l8t2447r171b2503],
21	have	VBP	O	have	advcl	14	SENT_98	[p6l205t2448r358b2503],
22	a	DT	O	a	det	25	SENT_98	[p6l388t2462r425b2503],
23	prolonged	JJ	O	prolonged	amod	25	SENT_98	[p6l456t2448r788b2518],
24	clinical	JJ	O	clinical	amod	25	SENT_98	[p6l819t2448r1041b2503],
25	course	NN	O	course	dobj	21	SENT_98	[p6l1073t2462r1297b2503],
26	and	CC	O	and	_	0	SENT_98	[p6l1326t2448r1445b2503],
27	higher	JJR	O	higher	amod	29	SENT_98	[p6l1479t2448r1683b2518],
28	mortality	NN	O	mortality	nn	29	SENT_98	[p6l1712t2448r1996b2517],
29	rate	NN	O	rate	dobj	21	SENT_98	[p6l2025t2451r2149b2503],
30	compared	VBN	O	compare	_	0	SENT_98	[p6l8t2550r343b2619],
31	to	TO	O	to	prepc_compared_to	21	SENT_98	[p6l375t2553r438b2605],
32	AGEP	NNP	O	AGEP	pobj	21	SENT_98	[p6l467t2549r682b2606],
33	.	.	O	.	_	0	SENT_98	[p6l467t2549r682b2606],

1	Clinicians	NNS	MISC	clinician	nsubj	11	SENT_99	[p6l718t2549r1034b2606],
2	should	MD	O	should	aux	4	SENT_99	[p6l1064t2550r1281b2605],
3	be	VB	O	be	cop	4	SENT_99	[p6l1317t2550r1396b2605],
4	aware	JJ	O	aware	_	0	SENT_99	[p6l1427t2564r1626b2605],
5	of	IN	O	of	_	0	SENT_99	[p6l1657t2550r1720b2605],
6	this	DT	O	this	det	8	SENT_99	[p6l1747t2550r1863b2605],
7	atypical	JJ	O	atypical	amod	8	SENT_99	[p6l1894t2550r2147b2620],
8	presentation	NN	O	presentation	prep_of	4	SENT_99	[p6l10t2652r419b2721],
9	and	CC	O	and	_	0	SENT_99	[p6l463t2652r583b2707],
10	should	MD	O	should	aux	11	SENT_99	[p6l628t2652r845b2707],
11	use	VB	O	use	conj_and	4	SENT_99	[p6l893t2666r1006b2707],
12	RegiSCAR	NN	O	regiscar	nn	13	SENT_99	[p6l1052t2651r1397b2722],
13	criteria	NNS	O	criterion	dobj	11	SENT_99	[p6l1441t2652r1665b2707],
14	early	RB	O	early	advmod	11	SENT_99	[p6l1707t2652r1864b2722],
15	to	TO	O	to	aux	16	SENT_99	[p6l1903t2655r1967b2707],
16	help	VB	O	help	dep	14	SENT_99	[p6l2013t2652r2149b2721],
17	make	VB	O	make	xcomp	16	SENT_99	[p6l10t2754r188b2809],
18	the	DT	O	the	det	19	SENT_99	[p6l214t2754r318b2809],
19	diagnosis	NN	O	diagnosis	dobj	17	SENT_99	[p6l347t2754r679b2824],
20	.	.	O	.	_	0	SENT_99	[p6l347t2754r679b2824],

1	Yu	NNP	PERSON	Yu	nn	3	SENT_100	[p6l34t2971r147b3032],
2	Chen	NNP	PERSON	Chen	nn	3	SENT_100	[p6l185t2967r387b3032],
3	HUANG	NNP	PERSON	HUANG	_	0	SENT_100	[p6l422t2948r829b3044],
4	}	CD	PERSON	}	num	6	SENT_100	[p6l422t2948r829b3044],
5	Po	NNP	PERSON	Po	nn	6	SENT_100	[p6l869t2970r965b3032],
6	Yu	NNP	PERSON	Yu	dep	3	SENT_100	[p6l1000t2971r1113b3032],
7	SHIH	NNP	PERSON	SHIH	nn	11	SENT_100	[p6l1150t2948r1424b3044],
8	,1	CD	NUMBER	,1	num	11	SENT_100	[p6l1150t2948r1424b3044],
9	Szu	NNP	O	Szu	nn	11	SENT_100	[p6l1467t2970r1594b3032],
10	Ying	NNP	O	Ying	nn	11	SENT_100	[p6l1626t2970r1811b3052],
11	CHIN	NNP	O	CHIN	dep	6	SENT_100	[p6l1846t2948r2148b3044],
12	?	.	O	?	_	0	SENT_100	[p6l1846t2948r2148b3044],

1	Ying	NNP	PERSON	Ying	nn	2	SENT_101	[p6l1396t3083r1580b3165],
2	Yi	NNP	PERSON	Yi	_	0	SENT_101	[p6l1610t3083r1700b3143],
3	CHIANG1	NN	O	chiang1	nn	4	SENT_101	[p6l1738t3061r2143b3145],
4	1Department	NN	O	1department	dep	2	SENT_101	[p6l327t3176r668b3258],
5	of	IN	O	of	_	0	SENT_101	[p6l694t3190r752b3258],
6	Dermatology	NNP	O	Dermatology	prep_of	4	SENT_101	[p6l764t3190r1117b3258],
7	,	,	O	,	_	0	SENT_101	[p6l764t3190r1117b3258],
8	Wan	NNP	ORGANIZATION	Wan	nn	10	SENT_101	[p6l1160t3194r1286b3242],
9	Fang	NNP	ORGANIZATION	Fang	nn	10	SENT_101	[p6l1313t3194r1448b3258],
10	Hospital	NNP	ORGANIZATION	Hospital	prep_of	4	SENT_101	[p6l1472t3190r1713b3258],
11	,	,	O	,	_	0	SENT_101	[p6l1472t3190r1713b3258],
12	Taipei	NNP	ORGANIZATION	Taipei	nn	14	SENT_101	[p6l1754t3191r1920b3258],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_101	[p6l1944t3190r2153b3241],
14	University	NNP	ORGANIZATION	University	conj_and	6	SENT_101	[p6l79t3276r362b3340],
15	,	,	O	,	_	0	SENT_101	[p6l79t3276r362b3340],
16	Taipei	NNP	LOCATION	Taipei	conj_and	6	SENT_101	[p6l402t3274r582b3340],
17	,	,	O	,	_	0	SENT_101	[p6l402t3274r582b3340],
18	and	CC	O	and	_	0	SENT_101	[p6l617t3272r714b3323],
19	2Department	NN	O	2department	conj_and	6	SENT_101	[p6l738t3258r1082b3340],
20	of	IN	O	of	_	0	SENT_101	[p6l1109t3272r1166b3340],
21	Dermatology	NNP	O	Dermatology	prep_of	19	SENT_101	[p6l1179t3272r1533b3340],
22	,	,	O	,	_	0	SENT_101	[p6l1179t3272r1533b3340],
23	Shuang	NNP	PERSON	Shuang	nn	25	SENT_101	[p6l1569t3272r1768b3340],
24	Ho	NNP	PERSON	Ho	nn	25	SENT_101	[p6l1792t3276r1877b3323],
25	Hospital	NNP	PERSON	Hospital	conj_and	6	SENT_101	[p6l1904t3272r2144b3340],
26	,	,	O	,	_	0	SENT_101	[p6l1904t3272r2144b3340],
27	Taipei	NNP	ORGANIZATION	Taipei	nn	29	SENT_101	[p6l675t3367r840b3434],
28	Medical	NNP	ORGANIZATION	Medical	nn	29	SENT_101	[p6l865t3366r1074b3417],
29	University	NNP	ORGANIZATION	University	conj_and	6	SENT_101	[p6l1105t3369r1388b3434],
30	,	,	O	,	_	0	SENT_101	[p6l1105t3369r1388b3434],
31	New	NNP	LOCATION	New	nn	33	SENT_101	[p6l1422t3369r1551b3417],
32	Taipei	NNP	LOCATION	Taipei	nn	33	SENT_101	[p6l1582t3367r1748b3434],
33	City	NNP	LOCATION	City	prep_of	4	SENT_101	[p6l1779t3368r1912b3434],
34	,	,	O	,	_	0	SENT_101	[p6l1779t3368r1912b3434],
35	Taiwan	NNP	LOCATION	Taiwan	prep_of	4	SENT_101	[p6l1952t3367r2151b3418],

1	REFERENCES	NNS	O	reference	_	0	SENT_102	[p6l12t3597r636b3668],

1	1	CD	NUMBER	1	num	3	SENT_103	[p7l11t57r29b105],
2	Kardaun	NN	ORGANIZATION	kardaun	nn	3	SENT_103	[p7l84t57r323b105],
3	SH	NN	ORGANIZATION	sh	_	0	SENT_103	[p7l366t56r465b114],
4	,	,	O	,	_	0	SENT_103	[p7l366t56r465b114],
5	Sidoroff	NNP	O	Sidoroff	nn	6	SENT_103	[p7l509t56r738b106],
6	A	NNP	O	A	appos	3	SENT_103	[p7l773t57r829b114],
7	,	,	O	,	_	0	SENT_103	[p7l773t57r829b114],
8	Valeyrie-Allanore	NNP	O	Valeyrie-Allanore	nn	9	SENT_103	[p7l869t57r1361b118],
9	L	NNP	O	L	appos	3	SENT_103	[p7l1404t57r1436b105],
10	et	FW	O	et	nn	11	SENT_103	[p7l1471t60r1527b105],
11	al.	FW	O	al.	dep	9	SENT_103	[p7l1550t57r1609b105],
12	.	.	O	.	_	0	SENT_103	[p7l1550t57r1609b105],

1	Variability	NN	O	variability	dobj	20	SENT_104	[p7l1653t57r1936b118],
2	in	IN	O	in	_	0	SENT_104	[p7l1977t57r2019b105],
3	the	DT	O	the	det	5	SENT_104	[p7l2059t57r2149b105],
4	clinical	JJ	O	clinical	amod	5	SENT_104	[p7l81t141r276b189],
5	pattern	NN	O	pattern	prep_in	1	SENT_104	[p7l327t143r528b201],
6	of	IN	O	of	_	0	SENT_104	[p7l578t140r633b189],
7	cutaneous	JJ	O	cutaneous	amod	8	SENT_104	[p7l678t143r980b189],
8	side-effects	NNS	O	side-effect	prep_of	5	SENT_104	[p7l1027t140r1369b189],
9	of	IN	O	of	_	0	SENT_104	[p7l1417t140r1472b189],
10	drugs	NNS	O	drug	prep_of	8	SENT_104	[p7l1517t141r1681b202],
11	with	IN	O	with	_	0	SENT_104	[p7l1727t141r1843b189],
12	systemic	JJ	O	systemic	amod	13	SENT_104	[p7l1892t141r2148b202],
13	symptoms	NNS	O	symptom	prep_with	10	SENT_104	[p7l81t228r400b286],
14	:	:	O	:	_	0	SENT_104	[p7l81t228r400b286],
15	does	VBZ	O	do	aux	20	SENT_104	[p7l447t226r588b274],
16	a	DT	O	a	det	18	SENT_104	[p7l632t238r665b274],
17	DRESS	NN	O	dress	nn	18	SENT_104	[p7l711t225r920b274],
18	syndrome	NN	O	syndrome	nsubj	20	SENT_104	[p7l965t226r1253b286],
19	really	RB	O	really	advmod	20	SENT_104	[p7l1299t226r1449b286],
20	exist	VB	O	exist	_	0	SENT_104	[p7l1492t225r1659b274],
21	?	.	O	?	_	0	SENT_104	[p7l1492t225r1659b274],

1	Br	NN	O	br	nn	2	SENT_105	[p7l1704t226r1773b273],
2	J	NN	O	j	_	0	SENT_105	[p7l1809t226r1844b274],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_105	[p7l1884t226r2152b274],
4	2007	CD	DATE	2007	dep	2	SENT_105	[p7l80t308r237b364],
5	;	:	O	;	_	0	SENT_105	[p7l80t308r237b364],
6	156	CD	NUMBER	156	num	8	SENT_105	[p7l269t308r386b356],
7	:	:	O	:	_	0	SENT_105	[p7l269t308r386b356],
8	609-610	CD	NUMBER	609-610	dep	2	SENT_105	[p7l416t308r676b356],
9	.	.	O	.	_	0	SENT_105	[p7l416t308r676b356],

1	2	CD	NUMBER	2	num	3	SENT_106	[p7l7t393r38b440],
2	Sidoroff	NN	O	sidoroff	nn	3	SENT_106	[p7l81t391r311b441],
3	A	NN	O	a	_	0	SENT_106	[p7l346t392r402b449],
4	,	,	O	,	_	0	SENT_106	[p7l346t392r402b449],
5	Halevy	NNP	PERSON	Halevy	nn	6	SENT_106	[p7l449t392r641b453],
6	S	NNP	O	S	appos	3	SENT_106	[p7l681t391r734b449],
7	,	,	O	,	_	0	SENT_106	[p7l681t391r734b449],
8	Bavinck	NNP	ORGANIZATION	Bavinck	nn	9	SENT_106	[p7l781t392r1009b441],
9	JNB	NNP	ORGANIZATION	JNB	appos	3	SENT_106	[p7l1047t392r1185b449],
10	,	,	O	,	_	0	SENT_106	[p7l1047t392r1185b449],
11	Vaillant	NNP	PERSON	Vaillant	nn	12	SENT_106	[p7l1228t392r1438b441],
12	L	NNP	O	L	appos	3	SENT_106	[p7l1480t392r1525b449],
13	,	,	O	,	_	0	SENT_106	[p7l1480t392r1525b449],
14	Roujeau	NNP	O	Roujeau	nn	15	SENT_106	[p7l1572t392r1804b453],
15	JC	NNP	O	JC	appos	3	SENT_106	[p7l1845t391r1938b441],
16	.	.	O	.	_	0	SENT_106	[p7l1845t391r1938b441],

1	Acute	JJ	O	acute	nsubj	2	SENT_107	[p7l1980t392r2149b441],
2	generalized	VBN	O	generalize	_	0	SENT_107	[p7l81t476r412b537],
3	exanthematous	JJ	O	exanthematous	amod	4	SENT_107	[p7l457t476r906b524],
4	pustulosis	NN	O	pustulosis	dep	2	SENT_107	[p7l950t476r1241b536],
5	(	CD	NUMBER	(	num	6	SENT_107	[p7l1284t475r1487b536],
6	AGEP	NN	O	agep	dep	4	SENT_107	[p7l1284t475r1487b536],
7	)	CD	NUMBER	)	number	8	SENT_107	[p7l1284t475r1487b536],
8	—	CD	NUMBER	—	dep	4	SENT_107	[p7l1529t506r1563b509],
9	a	DT	O	a	det	12	SENT_107	[p7l1603t488r1635b524],
10	clinical	JJ	O	clinical	amod	12	SENT_107	[p7l1677t476r1871b524],
11	reaction	NN	O	reaction	nn	12	SENT_107	[p7l1917t476r2147b524],
12	pattern	NN	O	pattern	dep	8	SENT_107	[p7l83t563r301b621],
13	.	.	O	.	_	0	SENT_107	[p7l83t563r301b621],

1	J	NNP	O	J	nn	3	SENT_108	[p7l328t561r364b609],
2	Cutan	NNP	O	Cutan	nn	3	SENT_108	[p7l387t560r556b609],
3	Pathol	NNP	O	Pathol	_	0	SENT_108	[p7l581t560r767b609],
4	2001	CD	DATE	2001	num	3	SENT_108	[p7l790t561r946b617],
5	;	:	O	;	_	0	SENT_108	[p7l790t561r946b617],
6	28	CD	NUMBER	28	num	8	SENT_108	[p7l975t561r1060b609],
7	:	:	O	:	_	0	SENT_108	[p7l975t561r1060b609],
8	113-119	CD	NUMBER	113-119	dep	3	SENT_108	[p7l1092t561r1350b609],
9	.	.	O	.	_	0	SENT_108	[p7l1092t561r1350b609],

1	3	CD	NUMBER	3	num	3	SENT_109	[p7l7t644r39b692],
2	Chiou	NNP	O	Chiou	nn	3	SENT_109	[p7l81t643r247b693],
3	CC	NN	O	cc	_	0	SENT_109	[p7l282t643r387b701],
4	,	,	O	,	_	0	SENT_109	[p7l282t643r387b701],
5	Yang	NNP	ORGANIZATION	Yang	nn	6	SENT_109	[p7l422t644r570b705],
6	LC	NNP	ORGANIZATION	LC	appos	3	SENT_109	[p7l608t643r699b701],
7	,	,	O	,	_	0	SENT_109	[p7l608t643r699b701],
8	Hung	NNP	O	Hung	nn	9	SENT_109	[p7l739t644r887b705],
9	SI	NNP	O	SI	appos	3	SENT_109	[p7l923t643r975b693],
10	et	FW	O	et	nn	11	SENT_109	[p7l1010t647r1067b692],
11	al.	FW	O	al.	dep	9	SENT_109	[p7l1089t644r1148b692],
12	.	.	O	.	_	0	SENT_109	[p7l1089t644r1148b692],

1	Clinicopathological	JJ	O	clinicopathological	amod	2	SENT_110	[p7l1188t643r1740b705],
2	features	NNS	O	feature	_	0	SENT_110	[p7l1774t644r2009b692],
3	and	CC	O	and	_	0	SENT_110	[p7l2042t644r2146b692],
4	prognosis	NN	O	prognosis	conj_and	2	SENT_110	[p7l83t728r367b789],
5	of	IN	O	of	_	0	SENT_110	[p7l401t727r456b776],
6	drug	NN	O	drug	nn	7	SENT_110	[p7l486t728r615b789],
7	rash	NN	O	rash	prep_of	4	SENT_110	[p7l651t728r770b776],
8	with	IN	O	with	_	0	SENT_110	[p7l805t728r921b775],
9	eosinophilia	NN	O	eosinophilia	nn	12	SENT_110	[p7l956t728r1300b788],
10	and	CC	O	and	_	0	SENT_110	[p7l1333t728r1437b776],
11	systemic	JJ	O	systemic	nn	12	SENT_110	[p7l1472t728r1729b789],
12	symptoms	NNS	O	symptom	prep_with	7	SENT_110	[p7l1762t730r2080b789],
13	:	:	O	:	_	0	SENT_110	[p7l1762t730r2080b789],
14	a	DT	O	a	det	15	SENT_110	[p7l2117t740r2150b776],
15	study	NN	O	study	dep	2	SENT_110	[p7l81t812r240b873],
16	of	IN	O	of	_	0	SENT_110	[p7l265t812r320b861],
17	30	CD	NUMBER	30	num	18	SENT_110	[p7l343t813r412b861],
18	cases	NNS	O	case	prep_of	15	SENT_110	[p7l439t824r607b861],
19	in	IN	O	in	_	0	SENT_110	[p7l635t812r678b860],
20	Taiwan	NNP	LOCATION	Taiwan	prep_in	18	SENT_110	[p7l703t812r926b861],
21	.	.	O	.	_	0	SENT_110	[p7l703t812r926b861],

1	J	NNP	O	J	nn	5	SENT_111	[p7l953t812r988b861],
2	Eur	NNP	O	Eur	nn	5	SENT_111	[p7l1010t812r1112b861],
3	Acad	NNP	O	Acad	nn	5	SENT_111	[p7l1128t812r1284b861],
4	Dermatol	NNP	O	Dermatol	nn	5	SENT_111	[p7l1306t812r1573b861],
5	Venereol	NNP	O	Venereol	_	0	SENT_111	[p7l1600t812r1852b861],
6	2008	CD	DATE	2008	num	8	SENT_111	[p7l1875t813r2032b869],
7	;	:	O	;	_	0	SENT_111	[p7l1875t813r2032b869],
8	22	CD	NUMBER	22	dep	5	SENT_111	[p7l2061t813r2145b860],
9	:	:	O	:	_	0	SENT_111	[p7l2061t813r2145b860],
10	1044	CD	DATE	1044	number	11	SENT_111	[p7l85t896r415b945],
11	—	CD	DATE	—	dep	5	SENT_111	[p7l85t896r415b945],
12	1049	CD	DATE	1049	dep	11	SENT_111	[p7l85t896r415b945],
13	.	.	O	.	_	0	SENT_111	[p7l85t896r415b945],

1	4	CD	NUMBER	4	num	3	SENT_112	[p7l7t981r40b1028],
2	Kleier	NNP	ORGANIZATION	Kleier	nn	3	SENT_112	[p7l84t980r244b1029],
3	RS	NN	ORGANIZATION	r	_	0	SENT_112	[p7l293t979r389b1037],
4	,	,	O	,	_	0	SENT_112	[p7l293t979r389b1037],
5	Breneman	NNP	PERSON	Breneman	nn	6	SENT_112	[p7l442t980r736b1029],
6	DL	NNP	O	DL	appos	3	SENT_112	[p7l788t980r879b1037],
7	,	,	O	,	_	0	SENT_112	[p7l788t980r879b1037],
8	Boiko	NNP	PERSON	Boiko	nn	11	SENT_112	[p7l932t980r1094b1029],
9	S.	NNP	O	S.	nn	11	SENT_112	[p7l1142t979r1195b1029],
10	Generalized	NNP	O	Generalized	nn	11	SENT_112	[p7l1246t979r1589b1029],
11	pustulation	NN	O	pustulation	appos	3	SENT_112	[p7l1641t980r1957b1041],
12	as	IN	O	as	_	0	SENT_112	[p7l2005t992r2070b1029],
13	a	DT	O	a	det	14	SENT_112	[p7l2117t992r2150b1029],
14	manifestation	NN	O	manifestation	prep_as	11	SENT_112	[p7l83t1063r470b1112],
15	of	IN	O	of	_	0	SENT_112	[p7l510t1063r565b1112],
16	the	DT	O	the	det	19	SENT_112	[p7l598t1064r689b1112],
17	anticonvulsant	JJ	O	anticonvulsant	amod	19	SENT_112	[p7l726t1064r1147b1112],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_112	[p7l1186t1064r1634b1125],
19	syndrome	NN	O	syndrome	prep_of	14	SENT_112	[p7l1671t1064r1974b1125],
20	.	.	O	.	_	0	SENT_112	[p7l1671t1064r1974b1125],

1	Arch	NNP	O	Arch	nn	2	SENT_113	[p7l2010t1064r2147b1112],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_113	[p7l79t1147r347b1196],
3	1991	CD	DATE	1991	num	2	SENT_113	[p7l373t1148r526b1205],
4	;	:	O	;	_	0	SENT_113	[p7l373t1148r526b1205],
5	127	CD	NUMBER	127	num	7	SENT_113	[p7l558t1148r675b1195],
6	:	:	O	:	_	0	SENT_113	[p7l558t1148r675b1195],
7	1361-1364	CD	DATE	1361-1364	dep	2	SENT_113	[p7l708t1148r1038b1196],
8	.	.	O	.	_	0	SENT_113	[p7l708t1148r1038b1196],

1	5	CD	NUMBER	5	num	3	SENT_114	[p7l8t1233r39b1280],
2	Teo	NNP	ORGANIZATION	Teo	nn	3	SENT_114	[p7l79t1232r188b1280],
3	WL	NNP	ORGANIZATION	WL	_	0	SENT_114	[p7l228t1232r337b1289],
4	,	,	O	,	_	0	SENT_114	[p7l228t1232r337b1289],
5	Pang	NNP	PERSON	Pang	nn	6	SENT_114	[p7l385t1232r527b1293],
6	SM	NNP	O	SM	appos	3	SENT_114	[p7l570t1231r681b1289],
7	,	,	O	,	_	0	SENT_114	[p7l570t1231r681b1289],
8	Koh	NNP	PERSON	Koh	nn	9	SENT_114	[p7l728t1232r837b1280],
9	HY	NNP	PERSON	HY	appos	6	SENT_114	[p7l883t1232r981b1280],
10	.	.	O	.	_	0	SENT_114	[p7l883t1232r981b1280],

1	Allopurinol	NN	O	allopurinol	nn	3	SENT_115	[p7l1023t1232r1327b1292],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_115	[p7l1373t1232r1821b1293],
3	syndrome	NN	O	syndrome	nsubj	6	SENT_115	[p7l1861t1232r2149b1293],
4	with	IN	O	with	_	0	SENT_115	[p7l80t1316r196b1363],
5	acute	JJ	O	acute	prep_with	3	SENT_115	[p7l253t1318r412b1364],
6	generalized	VBN	O	generalize	_	0	SENT_115	[p7l467t1316r798b1377],
7	exanthematous	JJ	O	exanthematous	amod	9	SENT_115	[p7l855t1316r1304b1364],
8	pustulosis	NN	O	pustulosis	nn	9	SENT_115	[p7l1361t1316r1651b1376],
9	manifestations	NNS	O	manifestation	dobj	6	SENT_115	[p7l1708t1315r2145b1364],
10	.	.	O	.	_	0	SENT_115	[p7l1708t1315r2145b1364],

1	Cutan	NNP	MISC	Cutan	nn	3	SENT_116	[p7l81t1399r251b1448],
2	Ocul	NNP	MISC	Ocul	nn	3	SENT_116	[p7l278t1399r412b1448],
3	Toxicol	NNP	MISC	Toxicol	_	0	SENT_116	[p7l437t1400r642b1448],
4	2011	CD	DATE	2011	num	3	SENT_116	[p7l665t1400r822b1457],
5	;	:	O	;	_	0	SENT_116	[p7l665t1400r822b1457],
6	30	CD	NUMBER	30	num	8	SENT_116	[p7l850t1400r935b1448],
7	:	:	O	:	_	0	SENT_116	[p7l850t1400r935b1448],
8	243-244	CD	NUMBER	243-244	dep	3	SENT_116	[p7l964t1400r1225b1448],
9	.	.	O	.	_	0	SENT_116	[p7l964t1400r1225b1448],

1	©	RB	O	©	dep	2	SENT_117	[p7l474t1609r540b1674],
2	2012	CD	DATE	2012	dep	3	SENT_117	[p7l576t1612r753b1674],
3	Japanese	JJ	MISC	japanese	dep	5	SENT_117	[p7l778t1613r1094b1695],
4	Dermatological	NNP	O	Dermatological	nn	5	SENT_117	[p7l1130t1609r1698b1694],
5	Association	NNP	O	Association	_	0	SENT_117	[p7l1730t1612r2149b1674],

